* | If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- |
Exhibit number |
||
101. INS |
Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101. SCH |
Inline XBRL Taxonomy Extension Schema | |
101. CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase | |
101. DEF |
Inline XBRL Taxonomy Extension Definition Linkbase | |
101. LAB |
Inline XBRL Taxonomy Extension Label Linkbase | |
101. PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase | |
104 |
The cover page for the Company’s Interim Report on Form 6-K for the six months ended September 30, 2022, has been formatted in Inline XBRL |
Sumitomo Mitsui Financial Group, Inc. | ||
By: |
/s/ Toru Nakashima | |
Name: Toru Nakashima | ||
Title: Senior Managing Corporate Executive Officer Group Chief Financial Officer |
Page |
||||
1 |
||||
2 |
||||
2 |
||||
2 |
||||
4 |
||||
6 |
||||
7 |
||||
7 |
||||
8 |
||||
16 |
||||
20 |
||||
33 |
||||
36 |
||||
40 |
||||
40 |
||||
40 |
||||
40 |
For the fiscal year ended/ending March 31, |
||||||||||||||||||||||||||||||||
2021 |
2022 |
2023 |
||||||||||||||||||||||||||||||
3Q |
4Q |
1Q |
2Q |
3Q |
4Q |
1Q |
2Q |
|||||||||||||||||||||||||
Japanese GDP |
1.9% | (0.1%) | 0.3% | (0.5%) | 1.2% | (0.5%) | 1.1% | (0.2%) |
• | SMBC Nikko business suspension order |
• | SMBC Nikko business improvement order |
• | SMFG improvement measures order |
• | SMFG and SMBC reporting orders |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions, except per share data) |
||||||||
Interest income |
¥ | 1,424,087 | ¥ | 843,712 | ||||
Interest expense |
573,910 | 139,973 | ||||||
Net interest income |
850,177 | 703,739 | ||||||
Fee and commission income |
607,546 | 608,157 | ||||||
Fee and commission expense |
112,737 | 113,484 | ||||||
Net fee and commission income |
494,809 | 494,673 | ||||||
Net trading income |
565,037 | 94,980 | ||||||
Net income from financial assets and liabilities at fair value through profit or loss |
171,708 | 97,643 | ||||||
Net investment income (loss) |
(4,915 | ) | 62,549 | |||||
Other income |
85,818 | 52,595 | ||||||
Total operating income |
2,162,634 | 1,506,179 | ||||||
Impairment charges on financial assets |
88,025 | 18,770 | ||||||
Net operating income |
2,074,609 | 1,487,409 | ||||||
General and administrative expenses |
948,612 | 879,731 | ||||||
Other expenses |
162,686 | 126,224 | ||||||
Operating expenses |
1,111,298 | 1,005,955 | ||||||
Share of post-tax profit of associates and joint ventures |
61,241 | 27,899 | ||||||
Profit before tax |
1,024,552 | 509,353 | ||||||
Income tax expense |
247,158 | 140,759 | ||||||
Net profit |
¥ | 777,394 | ¥ | 368,594 | ||||
Profit attributable to: |
||||||||
Shareholders of Sumitomo Mitsui Financial Group, Inc. |
¥ | 762,185 | ¥ | 361,393 | ||||
Non-controlling interests |
9,603 | 1,836 | ||||||
Other equity instruments holders |
5,606 | 5,365 | ||||||
Earnings per share: |
||||||||
Basic |
¥ | 555.91 | ¥ | 263.66 | ||||
Diluted |
555.72 | 263.55 |
For the six months ended September 30, |
||||||||||||||||||||||||
2022 |
2021 |
|||||||||||||||||||||||
Average balance (3) |
Interest income |
Average rate |
Average balance (3) |
Interest income |
Average rate |
|||||||||||||||||||
(In millions, except percentages) |
||||||||||||||||||||||||
Interest-earning assets: |
||||||||||||||||||||||||
Interest-earning deposits with other banks: |
||||||||||||||||||||||||
Domestic offices |
¥ | 844,795 | ¥ | 2,371 | 0.56% | ¥ | 913,488 | ¥ | 1,093 | 0.24% | ||||||||||||||
Foreign offices |
11,158,056 | 86,580 | 1.55% | 6,550,680 | 7,026 | 0.21% | ||||||||||||||||||
Total |
12,002,851 | 88,951 | 1.48% | 7,464,168 | 8,119 | 0.22% | ||||||||||||||||||
Call loans and bills bought, reverse repurchase agreements and cash collateral on securities borrowed: |
||||||||||||||||||||||||
Domestic offices |
9,949,229 | 3,817 | 0.08% | 10,293,325 | (2,110 | ) | (0.04% | ) | ||||||||||||||||
Foreign offices |
4,569,739 | 25,855 | 1.13% | 3,739,481 | 10,637 | 0.57% | ||||||||||||||||||
Total |
14,518,968 | 29,672 | 0.41% | 14,032,806 | 8,527 | 0.12% | ||||||||||||||||||
Investment securities (1) : |
||||||||||||||||||||||||
Domestic offices |
21,184,849 | 37,279 | 0.35% | 19,729,366 | 21,161 | 0.21% | ||||||||||||||||||
Foreign offices |
6,147,879 | 55,133 | 1.79% | 5,335,167 | 37,595 | 1.41% | ||||||||||||||||||
Total |
27,332,728 | 92,412 | 0.68% | 25,064,533 | 58,756 | 0.47% | ||||||||||||||||||
Loans and advances (2) : |
||||||||||||||||||||||||
Domestic offices |
65,974,666 | 465,097 | 1.41% | 62,891,663 | 414,167 | 1.32% | ||||||||||||||||||
Foreign offices |
45,378,263 | 747,955 | 3.30% | 33,980,939 | 354,143 | 2.08% | ||||||||||||||||||
Total |
111,352,929 | 1,213,052 | 2.18% | 96,872,602 | 768,310 | 1.59% | ||||||||||||||||||
Total interest-earning assets: |
||||||||||||||||||||||||
Domestic offices |
97,953,539 | 508,564 | 1.04% | 93,827,842 | 434,311 | 0.93% | ||||||||||||||||||
Foreign offices |
67,253,937 | 915,523 | 2.72% | 49,606,267 | 409,401 | 1.65% | ||||||||||||||||||
Total |
¥ | 165,207,476 | ¥ | 1,424,087 | 1.72% | ¥ | 143,434,109 | ¥ | 843,712 | 1.18% | ||||||||||||||
For the six months ended September 30, |
||||||||||||||||||||||||
2022 |
2021 |
|||||||||||||||||||||||
Average balance (3) |
Interest expense |
Average rate |
Average balance (3) |
Interest expense |
Average rate |
|||||||||||||||||||
(In millions, except percentages) |
||||||||||||||||||||||||
Interest-bearing liabilities: |
||||||||||||||||||||||||
Deposits: |
||||||||||||||||||||||||
Domestic offices |
¥ | 100,678,351 | ¥ | 25,551 | 0.05% | ¥ | 96,524,376 | ¥ | 4,483 | 0.01% | ||||||||||||||
Foreign offices |
35,785,345 | 261,739 | 1.46% | 30,240,244 | 44,367 | 0.29% | ||||||||||||||||||
Total |
136,463,696 | 287,290 | 0.42% | 126,764,620 | 48,850 | 0.08% | ||||||||||||||||||
Call money and bills sold, repurchase agreements and cash collateral on securities lent: |
||||||||||||||||||||||||
Domestic offices |
10,968,681 | 34,093 | 0.62% | 10,955,227 | (975 | ) | (0.02% | ) | ||||||||||||||||
Foreign offices |
8,290,399 | 53,582 | 1.29% | 6,088,101 | 1,941 | 0.06% | ||||||||||||||||||
Total |
19,259,080 | 87,675 | 0.91% | 17,043,328 | 966 | 0.01% | ||||||||||||||||||
Borrowings and other interest-bearing liabilities: |
||||||||||||||||||||||||
Domestic offices |
19,392,604 | 27,754 | 0.29% | 19,111,918 | 15,091 | 0.16% | ||||||||||||||||||
Foreign offices |
818,075 | 31,299 | 7.65% | 831,375 | 8,182 | 1.97% | ||||||||||||||||||
Total |
20,210,679 | 59,053 | 0.58% | 19,943,293 | 23,273 | 0.23% | ||||||||||||||||||
Debt securities in issue: |
||||||||||||||||||||||||
Domestic offices |
8,160,989 | 112,072 | 2.75% | 9,161,443 | 45,983 | 1.00% | ||||||||||||||||||
Foreign offices |
2,278,082 | 16,667 | 1.46% | 2,113,310 | 2,034 | 0.19% | ||||||||||||||||||
Total |
10,439,071 | 128,739 | 2.47% | 11,274,753 | 48,017 | 0.85% | ||||||||||||||||||
Premiums for deposit insurance: |
||||||||||||||||||||||||
Domestic offices |
— | 10,074 | — | — | 18,020 | — | ||||||||||||||||||
Foreign offices |
— | 1,079 | — | — | 847 | — | ||||||||||||||||||
Total |
— | 11,153 | — | — | 18,867 | — | ||||||||||||||||||
Total interest-bearing liabilities: |
||||||||||||||||||||||||
Domestic offices |
139,200,625 | 209,544 | 0.30% | 135,752,964 | 82,602 | 0.12% | ||||||||||||||||||
Foreign offices |
47,171,901 | 364,366 | 1.54% | 39,273,030 | 57,371 | 0.29% | ||||||||||||||||||
Total |
¥ | 186,372,526 | ¥ | 573,910 | 0.62% | ¥ | 175,025,994 | ¥ | 139,973 | 0.16% | ||||||||||||||
Net interest income and interest rate spread |
¥ | 850,177 | 1.10% | ¥ | 703,739 | 1.02% | ||||||||||||||||||
(1) | Taxable investment securities and non-taxable investment securities are not disclosed separately because the aggregate effect of these average balances and interest income would not be material. In addition, the yields on tax-exempt obligations have not been calculated on a tax equivalent basis because the effect of such calculation would not be material. |
(2) | Loans and advances include impaired loans and advances. The amortized portion of net loan origination fees (costs) is included in interest income on loans and advances. |
(3) | Average balances are generally based on a daily average. Weekly, month-end or quarter-end averages are used for certain average balances where it is not practical to obtain applicable daily averages. The allocations of amounts between domestic and foreign are based on the location of the office. |
Six months ended September 30, 2022 compared to six months ended September 30, 2021 Increase / (decrease) |
||||||||||||
Volume |
Rate |
Net change |
||||||||||
(In millions) |
||||||||||||
Interest income: |
||||||||||||
Interest-earning deposits with other banks: |
||||||||||||
Domestic offices |
¥ | (88 | ) | ¥ | 1,366 | ¥ | 1,278 | |||||
Foreign offices |
7,903 | 71,651 | 79,554 | |||||||||
Total |
7,815 | 73,017 | 80,832 | |||||||||
Call loans and bills bought, reverse repurchase agreements and cash collateral on securities borrowed: |
||||||||||||
Domestic offices |
67 | 5,860 | 5,927 | |||||||||
Foreign offices |
2,795 | 12,423 | 15,218 | |||||||||
Total |
2,862 | 18,283 | 21,145 | |||||||||
Investment securities: |
||||||||||||
Domestic offices |
1,630 | 14,488 | 16,118 | |||||||||
Foreign offices |
6,287 | 11,251 | 17,538 | |||||||||
Total |
7,917 | 25,739 | 33,656 | |||||||||
Loans and advances: |
||||||||||||
Domestic offices |
20,928 | 30,002 | 50,930 | |||||||||
Foreign offices |
143,825 | 249,987 | 393,812 | |||||||||
Total |
164,753 | 279,989 | 444,742 | |||||||||
Total interest income: |
||||||||||||
Domestic offices |
22,537 | 51,716 | 74,253 | |||||||||
Foreign offices |
160,810 | 345,312 | 506,122 | |||||||||
Total |
¥ | 183,347 | ¥ | 397,028 | ¥ | 580,375 | ||||||
Six months ended September 30, 2022 compared to six months ended September 30, 2021 Increase / (decrease) |
||||||||||||
Volume |
Rate |
Net change |
||||||||||
(In millions) |
||||||||||||
Interest expense: |
||||||||||||
Deposits: |
||||||||||||
Domestic offices |
¥ | 217 | ¥ | 20,851 | ¥ | 21,068 | ||||||
Foreign offices |
9,451 | 207,921 | 217,372 | |||||||||
Total |
9,668 | 228,772 | 238,440 | |||||||||
Call money and bills sold, repurchase agreements and cash collateral on securities lent: |
||||||||||||
Domestic offices |
(1 | ) | 35,069 | 35,068 | ||||||||
Foreign offices |
896 | 50,745 | 51,641 | |||||||||
Total |
895 | 85,814 | 86,709 | |||||||||
Borrowings and other interest-bearing liabilities: |
||||||||||||
Domestic offices |
228 | 12,435 | 12,663 | |||||||||
Foreign offices |
(133 | ) | 23,250 | 23,117 | ||||||||
Total |
95 | 35,685 | 35,780 | |||||||||
Debt securities in issue: |
||||||||||||
Domestic offices |
(5,649 | ) | 71,738 | 66,089 | ||||||||
Foreign offices |
5,011 | 9,622 | 14,633 | |||||||||
Total |
(638 | ) | 81,360 | 80,722 | ||||||||
Premiums for deposit insurance: |
||||||||||||
Domestic offices |
(7,946 | ) | — | (7,946 | ) | |||||||
Foreign offices |
232 | — | 232 | |||||||||
Total |
(7,714 | ) | — | (7,714 | ) | |||||||
Total interest expense: |
||||||||||||
Domestic offices |
(13,151 | ) | 140,093 | 126,942 | ||||||||
Foreign offices |
15,457 | 291,538 | 306,995 | |||||||||
Total |
¥ | 2,306 | ¥ | 431,631 | ¥ | 433,937 | ||||||
Net interest income: |
||||||||||||
Domestic offices |
¥ | 35,688 | ¥ | (88,377 | ) | ¥ | (52,689 | ) | ||||
Foreign offices |
145,353 | 53,774 | 199,127 | |||||||||
Total |
¥ | 181,041 | ¥ | (34,603 | ) | ¥ | 146,438 | |||||
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Fee and commission income from: |
||||||||
Loans |
¥ | 68,340 | ¥ | 60,585 | ||||
Credit card business |
181,965 | 160,119 | ||||||
Guarantees |
35,386 | 32,579 | ||||||
Securities-related business |
55,537 | 84,673 | ||||||
Deposits |
8,560 | 8,300 | ||||||
Remittances and transfers |
73,526 | 72,036 | ||||||
Safe deposits |
2,051 | 2,021 | ||||||
Trust fees |
3,044 | 2,631 | ||||||
Investment trusts |
74,220 | 93,860 | ||||||
Agency |
4,630 | 4,574 | ||||||
Others |
100,287 | 86,779 | ||||||
Total fee and commission income |
607,546 | 608,157 | ||||||
Fee and commission expense from: |
||||||||
Remittances and transfers |
14,309 | 20,988 | ||||||
Others |
98,428 | 92,496 | ||||||
Total fee and commission expense |
112,737 | 113,484 | ||||||
Net fee and commission income |
¥ | 494,809 | ¥ | 494,673 | ||||
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Net trading income: |
||||||||
Interest rate |
¥ | 284,254 | ¥ | 77,974 | ||||
Foreign exchange |
335,488 | (19,312 | ) | |||||
Equity |
(56,203 | ) | 37,542 | |||||
Credit |
830 | (1,119 | ) | |||||
Others |
668 | (105 | ) | |||||
Total net trading income |
¥ | 565,037 | ¥ | 94,980 | ||||
Net income from financial assets and liabilities at fair value through profit or loss: |
||||||||
Net income from financial assets at fair value through profit or loss: |
||||||||
Net income from debt instruments |
¥ | 102,831 | ¥ | 99,650 | ||||
Net income from equity instruments |
464 | 1,355 | ||||||
Net income (loss) from financial liabilities designated at fair value through profit or loss |
68,413 | (3,362 | ) | |||||
Total net income from financial assets and liabilities at fair value through profit or loss |
¥ | 171,708 | ¥ | 97,643 | ||||
Net investment income (loss): |
||||||||
Net gain (loss) from disposal of debt instruments |
¥ | (54,143 | ) | ¥ | 21,134 | |||
Dividend income |
49,228 | 41,415 | ||||||
Total net investment income (loss) |
¥ | (4,915 | ) | ¥ | 62,549 | |||
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Loans and advances |
¥ | 86,989 | ¥ | 13,855 | ||||
Loan commitments |
(7,429 | ) | 7,694 | |||||
Financial guarantees |
8,465 | (2,779 | ) | |||||
Total impairment charges on financial assets |
¥ | 88,025 | ¥ | 18,770 | ||||
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Personnel expenses |
¥ | 449,445 | ¥ | 409,435 | ||||
Depreciation and amortization |
129,388 | 131,234 | ||||||
Building and maintenance expenses |
3,460 | 4,502 | ||||||
Supplies expenses |
7,002 | 7,766 | ||||||
Communication expenses |
15,101 | 15,972 | ||||||
Publicity and advertising expenses |
64,179 | 58,117 | ||||||
Taxes and dues |
43,988 | 42,861 | ||||||
Outsourcing expenses |
59,456 | 54,021 | ||||||
Office equipment expenses |
34,737 | 30,258 | ||||||
Others |
141,856 | 125,565 | ||||||
Total general and administrative expenses |
¥ | 948,612 | ¥ | 879,731 | ||||
Wholesale Business Unit |
Retail Business Unit |
Global Business Unit |
Global Markets Business Unit |
Head office account and others |
Total |
|||||||||||||||||||
(In billions) |
||||||||||||||||||||||||
Consolidated gross profit (1) |
¥ | 367.4 | ¥ | 553.8 | ¥ | 601.1 | ¥ | 266.0 | ¥ | (155.9 | ) | ¥ | 1,632.4 | |||||||||||
General and administrative expenses |
(145.5 | ) | (456.2 | ) | (314.7 | ) | (56.7 | ) | 10.5 | (962.6 | ) | |||||||||||||
Others (2) |
37.3 | 2.1 | 46.0 | 15.4 | (48.7 | ) | 52.1 | |||||||||||||||||
Consolidated net business profit |
¥ | 259.2 | ¥ | 99.7 | ¥ | 332.4 | ¥ | 224.7 | ¥ | (194.1 | ) | ¥ | 721.9 | |||||||||||
Wholesale Business Unit |
Retail Business Unit |
Global Business Unit |
Global Markets Business Unit |
Head office account and others |
Total |
|||||||||||||||||||
(In billions) |
||||||||||||||||||||||||
Consolidated gross profit (1) |
¥ | 329.5 | ¥ | 568.1 | ¥ | 394.5 | ¥ | 250.9 | ¥ | (111.7 | ) | ¥ | 1,431.3 | |||||||||||
General and administrative expenses |
(148.9 | ) | (464.9 | ) | (213.9 | ) | (43.0 | ) | (5.2 | ) | (875.9 | ) | ||||||||||||
Others (2) |
30.3 | 0.8 | 25.1 | 17.6 | (43.1 | ) | 30.7 | |||||||||||||||||
Consolidated net business profit |
¥ | 210.9 | ¥ | 104.0 | ¥ | 205.7 | ¥ | 225.5 | ¥ | (160.0 | ) | ¥ | 586.1 | |||||||||||
(1) | Consolidated gross profit = (Interest income – Interest expenses) + Trust fees + (Fee and commission income – Fee and commission expenses) + (Trading income – Trading losses) + (Other operating income – Other operating expenses). |
(2) | “Others” includes share of profit or loss of equity-method associates and joint ventures and cooperated profit and loss, that is, profit and loss double counted within our business segments in the managerial accounting. |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
Region: |
||||||||
Japan |
51 | % | 66 | % | ||||
Foreign: |
||||||||
Americas |
21 | % | 13 | % | ||||
Europe and Middle East |
9 | % | 8 | % | ||||
Asia and Oceania (excluding Japan) |
19 | % | 13 | % | ||||
Total |
100 | % | 100 | % | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Cash and deposits with banks |
¥ | 71,496,806 | ¥ | 75,697,521 | ||||
Call loans and bills bought |
6,968,074 | 1,965,135 | ||||||
Reverse repurchase agreements and cash collateral on securities borrowed |
10,325,747 | 11,303,930 | ||||||
Trading assets |
4,006,350 | 3,736,296 | ||||||
Derivative financial instruments |
13,268,003 | 6,443,748 | ||||||
Financial assets at fair value through profit or loss |
1,015,046 | 1,695,585 | ||||||
Investment securities |
26,995,630 | 32,749,405 | ||||||
Loans and advances |
115,535,519 | 104,635,815 | ||||||
Investments in associates and joint ventures |
1,123,339 | 1,009,738 | ||||||
Property, plant and equipment |
1,840,944 | 1,762,996 | ||||||
Intangible assets |
1,033,020 | 992,849 | ||||||
Other assets |
6,521,290 | 6,063,907 | ||||||
Current tax assets |
44,671 | 44,941 | ||||||
Deferred tax assets |
90,613 | 58,981 | ||||||
Total assets |
¥ | 260,265,052 | ¥ | 248,160,847 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Manufacturing |
¥ | 10,174,746 | ¥ | 10,105,370 | ||||
Agriculture, forestry, fisheries and mining |
479,358 | 378,366 | ||||||
Construction |
913,580 | 847,805 | ||||||
Transportation, communications and public enterprises |
6,488,241 | 6,210,330 | ||||||
Wholesale and retail |
6,120,993 | 5,903,439 | ||||||
Finance and insurance |
3,738,244 | 3,549,762 | ||||||
Real estate and goods rental and leasing |
14,620,611 | 14,314,582 | ||||||
Services |
4,856,856 | 4,860,235 | ||||||
Municipalities |
588,166 | 600,759 | ||||||
Lease financing |
15,594 | 18,476 | ||||||
Consumer (1) |
15,649,775 | 15,506,486 | ||||||
Others (2) |
1,973,131 | 1,893,474 | ||||||
Total domestic |
¥ | 65,619,295 | ¥ | 64,189,084 | ||||
(1) | The balance in Consumer mainly consists of housing loans. The housing loan balances amounted to ¥10,641,047 million and ¥10,676,967 million at September 30, 2022 and March 31, 2022, respectively. |
(2) | The balance in Others includes loans and advances to the Government of Japan. |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Public sector |
¥ | 501,074 | ¥ | 440,236 | ||||
Financial institutions |
10,421,340 | 8,311,518 | ||||||
Commerce and industry |
33,965,086 | 28,838,245 | ||||||
Lease financing |
303,674 | 290,097 | ||||||
Others |
6,106,399 | 3,884,519 | ||||||
Total foreign |
¥ | 51,297,573 | ¥ | 41,764,615 | ||||
For the fiscal year ending March 31, |
||||||||
2023 |
2024 |
|||||||
(%) |
||||||||
Japanese GDP |
2.0 | 2.0 | ||||||
Global GDP |
2.9 | 2.9 |
At September 30, 2022 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Allowance for loan losses: |
||||||||||||||||
Balance at April 1, 2022 |
¥ | 162,919 | ¥ | 247,020 | ¥ | 583,115 | ¥ | 993,054 | ||||||||
Net transfers between stages |
(7,616 | ) | (8,529 | ) | 16,145 | — | ||||||||||
Provision for loan losses |
12,104 | 5,737 | 69,148 | 86,989 | ||||||||||||
Charge-offs (1) |
— | — | 142,198 | 142,198 | ||||||||||||
Recoveries |
— | — | 10,467 | 10,467 | ||||||||||||
Net charge-offs |
— | — | 131,731 | 131,731 | ||||||||||||
Others (2) |
7,882 | 14,052 | 19,922 | 41,856 | ||||||||||||
Balance at September 30, 2022 |
¥ | 175,289 | ¥ | 258,280 | ¥ | 556,599 | ¥ | 990,168 | ||||||||
At September 30, 2021 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Allowance for loan losses: |
||||||||||||||||
Balance at April 1, 2021 |
¥ | 170,156 | ¥ | 255,909 | ¥ | 423,222 | ¥ | 849,287 | ||||||||
Net transfers between stages |
(8,713 | ) | (1,465 | ) | 10,178 | — | ||||||||||
Provision (credit) for loan losses |
(2,382 | ) | (14,193 | ) | 30,430 | 13,855 | ||||||||||
Charge-offs (1) |
— | — | 72,949 | 72,949 | ||||||||||||
Recoveries |
— | — | 7,032 | 7,032 | ||||||||||||
Net charge-offs |
— | — | 65,917 | 65,917 | ||||||||||||
Others (2) |
828 | 1,131 | 824 | 2,783 | ||||||||||||
Balance at September 30, 2021 |
¥ | 159,889 | ¥ | 241,382 | ¥ | 398,737 | ¥ | 800,008 | ||||||||
(1) | Charge-offs consist of the reduction of the allowance through the sales of loans and write-offs. |
(2) | Others mainly include foreign exchange translations for the six months ended September 30, 2022 and 2021. |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Potentially bankrupt, virtually bankrupt and bankrupt (loans and advances): |
||||||||
Domestic: |
||||||||
Manufacturing |
¥ | 229,261 | ¥ | 223,198 | ||||
Agriculture, forestry, fisheries and mining |
2,002 | 2,503 | ||||||
Construction |
7,324 | 7,366 | ||||||
Transportation, communications and public enterprises |
60,170 | 48,614 | ||||||
Wholesale and retail |
65,854 | 72,999 | ||||||
Finance and insurance |
2,557 | 2,784 | ||||||
Real estate and goods rental and leasing |
31,560 | 36,628 | ||||||
Services |
87,289 | 83,384 | ||||||
Consumer |
133,137 | 131,220 | ||||||
Others |
5,988 | 8,172 | ||||||
Total domestic |
625,142 | 616,868 | ||||||
Foreign: |
||||||||
Financial institutions |
14,505 | 10,647 | ||||||
Commerce and industry |
310,489 | 239,659 | ||||||
Others |
31,076 | 26,547 | ||||||
Total foreign |
356,070 | 276,853 | ||||||
Total |
981,212 | 893,721 | ||||||
Past due three months or more (loans): |
||||||||
Domestic |
30,420 | 36,593 | ||||||
Foreign |
2 | — | ||||||
Total |
30,422 | 36,593 | ||||||
Restructured (loans): |
||||||||
Domestic |
175,476 | 238,824 | ||||||
Foreign |
144,028 | 113,166 | ||||||
Total |
319,504 | 351,990 | ||||||
Other impaired (loans and advances): |
||||||||
Domestic |
52,269 | 32,534 | ||||||
Foreign |
7,817 | 91,256 | ||||||
Total |
60,086 | 123,790 | ||||||
Gross impaired loans and advances |
1,391,224 | 1,406,094 | ||||||
Less: Allowance for loan losses for impaired loans and advances |
(556,599 | ) | (583,115 | ) | ||||
Net impaired loans and advances |
¥ | 834,625 | ¥ | 822,979 | ||||
At September 30, 2022 |
||||||||||||||||
Amortized cost (1) |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
|||||||||||||
(In millions) |
||||||||||||||||
Debt instruments at amortized cost: |
||||||||||||||||
Domestic: |
||||||||||||||||
Japanese government bonds |
¥ | 72,543 | ¥ | — | ¥ | 118 | ¥ | 72,425 | ||||||||
Japanese municipal bonds |
43,706 | — | 441 | 43,265 | ||||||||||||
Total domestic |
116,249 | — | 559 | 115,690 | ||||||||||||
Foreign: |
||||||||||||||||
Bonds issued by other governments and official institutions (2) |
60,802 | 351 | 36 | 61,117 | ||||||||||||
Other debt instruments |
1,415 | 29 | — | 1,444 | ||||||||||||
Total foreign |
62,217 | 380 | 36 | 62,561 | ||||||||||||
Total |
¥ | 178,466 | ¥ | 380 | ¥ | 595 | ¥ | 178,251 | ||||||||
Debt instruments at fair value through other comprehensive income: |
||||||||||||||||
Domestic: |
||||||||||||||||
Japanese government bonds |
¥ | 10,035,719 | ¥ | 837 | ¥ | 48,456 | ¥ | 9,988,100 | ||||||||
Japanese municipal bonds |
1,101,395 | 8 | 15,685 | 1,085,718 | ||||||||||||
Japanese corporate bonds |
1,090,683 | 227 | 13,703 | 1,077,207 | ||||||||||||
Other debt instruments |
311 | — | — | 311 | ||||||||||||
Total domestic |
12,228,108 | 1,072 | 77,844 | 12,151,336 | ||||||||||||
Foreign: |
||||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
6,362,793 | 221 | 725,560 | 5,637,454 | ||||||||||||
Bonds issued by other governments and official institutions (2) |
3,117,453 | 744 | 130,884 | 2,987,313 | ||||||||||||
Mortgage-backed securities |
1,345,135 | 206 | 184,294 | 1,161,047 | ||||||||||||
Other debt instruments |
540,120 | 1,175 | 3,853 | 537,442 | ||||||||||||
Total foreign |
11,365,501 | 2,346 | 1,044,591 | 10,323,256 | ||||||||||||
Total |
¥ | 23,593,609 | ¥ | 3,418 | ¥ | 1,122,435 | ¥ | 22,474,592 | ||||||||
Equity instruments at fair value through other comprehensive income: |
||||||||||||||||
Domestic |
¥ | 1,366,291 | ¥ | 2,160,784 | ¥ | 73,969 | ¥ | 3,453,106 | ||||||||
Foreign |
264,526 | 634,472 | 9,532 | 889,466 | ||||||||||||
Total |
¥ | 1,630,817 | ¥ | 2,795,256 | ¥ | 83,501 | ¥ | 4,342,572 | ||||||||
At March 31, 2022 |
||||||||||||||||
Amortized cost (1) |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
|||||||||||||
(In millions) |
||||||||||||||||
Debt instruments at amortized cost: |
||||||||||||||||
Domestic: |
||||||||||||||||
Japanese municipal bonds |
¥ | 25,741 | ¥ | — | ¥ | 219 | ¥ | 25,522 | ||||||||
Total domestic |
25,741 | — | 219 | 25,522 | ||||||||||||
Foreign: |
||||||||||||||||
Bonds issued by other governments and official institutions (2) |
56,400 | 221 | 26 | 56,595 | ||||||||||||
Other debt instruments |
1,813 | 35 | — | 1,848 | ||||||||||||
Total foreign |
58,213 | 256 | 26 | 58,443 | ||||||||||||
Total |
¥ | 83,954 | ¥ | 256 | ¥ | 245 | ¥ | 83,965 | ||||||||
Debt instruments at fair value through other comprehensive income: |
||||||||||||||||
Domestic: |
||||||||||||||||
Japanese government bonds |
¥ | 15,819,486 | ¥ | 271 | ¥ | 45,560 | ¥ | 15,774,197 | ||||||||
Japanese municipal bonds |
1,154,542 | 71 | 9,117 | 1,145,496 | ||||||||||||
Japanese corporate bonds |
956,320 | 498 | 7,826 | 948,992 | ||||||||||||
Other debt instruments |
311 | — | — | 311 | ||||||||||||
Total domestic |
17,930,659 | 840 | 62,503 | 17,868,996 | ||||||||||||
Foreign: |
||||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
6,027,640 | 4,719 | 350,570 | 5,681,789 | ||||||||||||
Bonds issued by other governments and official institutions (2) |
3,056,974 | 2,363 | 61,749 | 2,997,588 | ||||||||||||
Mortgage-backed securities |
1,058,908 | 893 | 53,750 | 1,006,051 | ||||||||||||
Other debt instruments |
513,186 | 808 | 1,452 | 512,542 | ||||||||||||
Total foreign |
10,656,708 | 8,783 | 467,521 | 10,197,970 | ||||||||||||
Total |
¥ | 28,587,367 | ¥ | 9,623 | ¥ | 530,024 | ¥ | 28,066,966 | ||||||||
Equity instruments at fair value through other comprehensive income: |
||||||||||||||||
Domestic |
¥ | 1,317,324 | ¥ | 2,401,838 | ¥ | 60,571 | ¥ | 3,658,591 | ||||||||
Foreign |
264,504 | 683,463 | 8,073 | 939,894 | ||||||||||||
Total |
¥ | 1,581,828 | ¥ | 3,085,301 | ¥ | 68,644 | ¥ | 4,598,485 | ||||||||
(1) | Amortized cost for equity instruments at fair value through other comprehensive income represents the difference between the fair value and gross unrealized gains or losses. |
(2) | Bonds issued by governments and official institutions excluding U.S. Treasury and other U.S. government agencies. |
At September 30, 2022 |
||||||||||||||||||||||||
Less than twelve months |
Twelve months or more |
Total |
||||||||||||||||||||||
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
|||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Debt instruments at amortized cost: |
||||||||||||||||||||||||
Domestic: |
||||||||||||||||||||||||
Japanese government bonds |
¥ | 72,425 | ¥ | 118 | ¥ | — | ¥ | — | ¥ | 72,425 | ¥ | 118 | ||||||||||||
Japanese municipal bonds |
27,837 | 169 | 15,428 | 272 | 43,265 | 441 | ||||||||||||||||||
Total domestic |
100,262 | 287 | 15,428 | 272 | 115,690 | 559 | ||||||||||||||||||
Foreign: |
||||||||||||||||||||||||
Bonds issued by other governments and official institutions (1) |
5,880 | 36 | — | — | 5,880 | 36 | ||||||||||||||||||
Other debt instruments |
— | — | — | — | — | — | ||||||||||||||||||
Total foreign |
5,880 | 36 | — | — | 5,880 | 36 | ||||||||||||||||||
Total |
¥ | 106,142 | ¥ | 323 | ¥ | 15,428 | ¥ | 272 | ¥ | 121,570 | ¥ | 595 | ||||||||||||
Debt instruments at fair value through other comprehensive income: |
||||||||||||||||||||||||
Domestic: |
||||||||||||||||||||||||
Japanese government bonds |
¥ | 1,603,723 | ¥ | 10,435 | ¥ | 2,088,446 | ¥ | 38,021 | ¥ | 3,692,169 | ¥ | 48,456 | ||||||||||||
Japanese municipal bonds |
662,019 | 10,084 | 406,211 | 5,601 | 1,068,230 | 15,685 | ||||||||||||||||||
Japanese corporate bonds |
476,730 | 6,994 | 316,604 | 6,709 | 793,334 | 13,703 | ||||||||||||||||||
Other debt instruments |
— | — | — | — | — | — | ||||||||||||||||||
Total domestic |
2,742,472 | 27,513 | 2,811,261 | 50,331 | 5,553,733 | 77,844 | ||||||||||||||||||
Foreign: |
||||||||||||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
3,381,150 | 307,911 | 2,214,087 | 417,649 | 5,595,237 | 725,560 | ||||||||||||||||||
Bonds issued by other governments and official institutions (1) |
2,251,768 | 13,411 | 452,058 | 117,473 | 2,703,826 | 130,884 | ||||||||||||||||||
Mortgage-backed securities |
538,562 | 72,487 | 476,945 | 111,807 | 1,015,507 | 184,294 | ||||||||||||||||||
Other debt instruments |
259,104 | 3,851 | 628 | 2 | 259,732 | 3,853 | ||||||||||||||||||
Total foreign |
6,430,584 | 397,660 | 3,143,718 | 646,931 | 9,574,302 | 1,044,591 | ||||||||||||||||||
Total |
¥ | 9,173,056 | ¥ | 425,173 | ¥ | 5,954,979 | ¥ | 697,262 | ¥ | 15,128,035 | ¥ | 1,122,435 | ||||||||||||
Equity instruments at fair value through other comprehensive income: |
||||||||||||||||||||||||
Domestic |
¥ | 172,782 | ¥ | 22,735 | ¥ | 107,440 | ¥ | 51,234 | ¥ | 280,222 | ¥ | 73,969 | ||||||||||||
Foreign |
47,083 | 6,024 | 7,510 | 3,508 | 54,593 | 9,532 | ||||||||||||||||||
Total |
¥ | 219,865 | ¥ | 28,759 | ¥ | 114,950 | ¥ | 54,742 | ¥ | 334,815 | ¥ | 83,501 | ||||||||||||
At March 31, 2022 |
||||||||||||||||||||||||
Less than twelve months |
Twelve months or more |
Total |
||||||||||||||||||||||
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
|||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Debt instruments at amortized cost: |
||||||||||||||||||||||||
Domestic: |
||||||||||||||||||||||||
Japanese municipal bonds |
¥ | 9,987 | ¥ | 55 | ¥ | 15,535 | ¥ | 164 | ¥ | 25,522 | ¥ | 219 | ||||||||||||
Total domestic |
9,987 | 55 | 15,535 | 164 | 25,522 | 219 | ||||||||||||||||||
Foreign: |
||||||||||||||||||||||||
Bonds issued by other governments and official institutions (1) |
4,437 | 26 | — | — | 4,437 | 26 | ||||||||||||||||||
Other debt instruments |
— | — | — | — | — | — | ||||||||||||||||||
Total foreign |
4,437 | 26 | — | — | 4,437 | 26 | ||||||||||||||||||
Total |
¥ | 14,424 | ¥ | 81 | ¥ | 15,535 | ¥ | 164 | ¥ | 29,959 | ¥ | 245 | ||||||||||||
Debt instruments at fair value through other comprehensive income: |
||||||||||||||||||||||||
Domestic: |
||||||||||||||||||||||||
Japanese government bonds |
¥ | 8,580,932 | ¥ | 26,384 | ¥ | 4,867,170 | ¥ | 19,176 | ¥ | 13,448,102 | ¥ | 45,560 | ||||||||||||
Japanese municipal bonds |
832,211 | 7,429 | 267,449 | 1,688 | 1,099,660 | 9,117 | ||||||||||||||||||
Japanese corporate bonds |
497,623 | 3,965 | 269,460 | 3,861 | 767,083 | 7,826 | ||||||||||||||||||
Other debt instruments |
— | — | — | — | — | — | ||||||||||||||||||
Total domestic |
9,910,766 | 37,778 | 5,404,079 | 24,725 | 15,314,845 | 62,503 | ||||||||||||||||||
Foreign: |
||||||||||||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
3,372,465 | 197,844 | 1,468,597 | 152,726 | 4,841,062 | 350,570 | ||||||||||||||||||
Bonds issued by other governments and official institutions (1) |
1,783,823 | 5,865 | 587,846 | 55,884 | 2,371,669 | 61,749 | ||||||||||||||||||
Mortgage-backed securities |
631,780 | 27,826 | 293,412 | 25,924 | 925,192 | 53,750 | ||||||||||||||||||
Other debt instruments |
223,464 | 1,450 | 1,071 | 2 | 224,535 | 1,452 | ||||||||||||||||||
Total foreign |
6,011,532 | 232,985 | 2,350,926 | 234,536 | 8,362,458 | 467,521 | ||||||||||||||||||
Total |
¥ | 15,922,298 | ¥ | 270,763 | ¥ | 7,755,005 | ¥ | 259,261 | ¥ | 23,677,303 | ¥ | 530,024 | ||||||||||||
Equity instruments at fair value through other comprehensive income: |
||||||||||||||||||||||||
Domestic |
¥ | 82,040 | ¥ | 8,396 | ¥ | 128,728 | ¥ | 52,175 | ¥ | 210,768 | ¥ | 60,571 | ||||||||||||
Foreign |
42,261 | 4,519 | 10,268 | 3,554 | 52,529 | 8,073 | ||||||||||||||||||
Total |
¥ | 124,301 | ¥ | 12,915 | ¥ | 138,996 | ¥ | 55,729 | ¥ | 263,297 | ¥ | 68,644 | ||||||||||||
(1) | Bonds issued by governments and official institutions excluding U.S. Treasury and other U.S. government agencies. |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Debt instruments |
¥ | 3,916,236 | ¥ | 3,489,258 | ||||
Equity instruments |
90,114 | 247,038 | ||||||
Total trading assets |
¥ | 4,006,350 | ¥ | 3,736,296 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Debt instruments |
¥ | 973,394 | ¥ | 1,657,206 | ||||
Equity instruments |
41,652 | 38,379 | ||||||
Total financial assets at fair value through profit or loss |
¥ | 1,015,046 | ¥ | 1,695,585 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Deposits |
¥ | 172,728,298 | ¥ | 162,593,492 | ||||
Call money and bills sold |
1,157,519 | 1,130,000 | ||||||
Repurchase agreements and cash collateral on securities lent |
17,962,121 | 20,113,162 | ||||||
Trading liabilities |
2,980,561 | 3,181,992 | ||||||
Derivative financial instruments |
15,366,589 | 6,966,336 | ||||||
Financial liabilities designated at fair value through profit or loss |
422,729 | 455,734 | ||||||
Borrowings |
13,806,074 | 20,584,651 | ||||||
Debt securities in issue |
11,948,252 | 11,428,437 | ||||||
Provisions |
203,791 | 227,784 | ||||||
Other liabilities |
9,796,648 | 8,386,774 | ||||||
Current tax liabilities |
87,737 | 51,513 | ||||||
Deferred tax liabilities |
175,199 | 259,280 | ||||||
Total liabilities |
¥ | 246,635,518 | ¥ | 235,379,155 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Domestic offices: |
||||||||
Non-interest-bearing demand deposits |
¥ | 29,612,064 | ¥ | 28,633,073 | ||||
Interest-bearing demand deposits |
67,902,316 | 67,287,154 | ||||||
Deposits at notice |
665,899 | 691,249 | ||||||
Time deposits |
17,455,023 | 17,624,597 | ||||||
Negotiable certificates of deposit |
4,192,019 | 5,059,074 | ||||||
Others |
10,417,073 | 9,625,768 | ||||||
Total domestic offices |
130,244,394 | 128,920,915 | ||||||
Foreign offices: |
||||||||
Non-interest-bearing demand deposits |
2,803,143 | 2,334,805 | ||||||
Interest-bearing demand deposits |
4,956,330 | 4,221,047 | ||||||
Deposits at notice |
14,021,985 | 11,345,294 | ||||||
Time deposits |
10,104,866 | 7,513,141 | ||||||
Negotiable certificates of deposit |
10,321,048 | 8,010,723 | ||||||
Others |
276,532 | 247,567 | ||||||
Total foreign offices |
42,483,904 | 33,672,577 | ||||||
Total deposits |
¥ | 172,728,298 | ¥ | 162,593,492 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Unsubordinated borrowings |
¥ | 12,029,633 | ¥ | 18,766,117 | ||||
Subordinated borrowings |
219,210 | 234,680 | ||||||
Liabilities associated with securitization transactions |
1,178,378 | 1,200,147 | ||||||
Lease liabilities |
378,853 | 383,707 | ||||||
Total borrowings |
¥ | 13,806,074 | ¥ | 20,584,651 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Commercial paper |
¥ | 2,588,279 | ¥ | 2,424,579 | ||||
Unsubordinated bonds |
8,316,555 | 8,000,837 | ||||||
Subordinated bonds |
1,043,418 | 1,003,021 | ||||||
Total debt securities in issue |
¥ | 11,948,252 | ¥ | 11,428,437 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Capital stock |
¥ | 2,342,537 | ¥ | 2,341,878 | ||||
Capital surplus |
645,584 | 645,382 | ||||||
Retained earnings |
7,143,778 | 6,434,605 | ||||||
Treasury stock |
(13,117 | ) | (13,403 | ) | ||||
Equity excluding other reserves |
10,118,782 | 9,408,462 | ||||||
Other reserves |
2,669,330 | 2,546,294 | ||||||
Equity attributable to shareholders of Sumitomo Mitsui Financial Group, Inc. |
12,788,112 | 11,954,756 | ||||||
Non-controlling interests |
106,809 | 93,325 | ||||||
Equity attributable to other equity instruments holders |
734,613 | 733,611 | ||||||
Total equity |
¥ | 13,629,534 | ¥ | 12,781,692 | ||||
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Loans and advances |
¥ | 115,535,519 | ¥ | 104,635,815 | ||||
Deposits |
172,728,298 | 162,593,492 |
At December 9, 2022 | ||||||||||||||||
Moody’s |
S&P |
Fitch | ||||||||||||||
Long-term |
Outlook |
Short-term |
Long-term |
Outlook |
Short-term |
Long-term |
Outlook |
Short-term | ||||||||
A1 |
S | P-1 |
A- | S | — | A- | S | F1 |
At December 9, 2022 | ||||||||||||||||
Moody’s |
S&P |
Fitch | ||||||||||||||
Long-term |
Outlook |
Short-term |
Long-term |
Outlook |
Short-term |
Long-term |
Outlook |
Short-term | ||||||||
A1 |
S | P-1 |
A | S | A-1 |
A- | S | F1 |
For the three months ended September 30, 2022 (1) |
||||
SMFG (consolidated) |
130.2 | % | ||
SMBC (consolidated) |
133.7 | % | ||
SMBC (nonconsolidated) |
135.1 | % |
(1) | Under the FSA’s LCR guidelines, the LCR for the three months ended September 30, 2022 is set as the three-month average of daily LCRs for the same three months, which is calculated by dividing the balance of high-quality liquid assets by the total net cash outflows on a daily basis for the same three months. |
At September 30, 2022 (1) |
||||
SMFG (consolidated) |
120.4 | % | ||
SMBC (consolidated) |
127.7 | % | ||
SMBC (nonconsolidated) |
124.9 | % |
(1) | Under the FSA’s NSFR guidelines, the NSFR is calculated by dividing the available amount of stable funding by the required amount of stable funding. |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In billions, except percentages) |
||||||||
SMFG Consolidated: |
||||||||
Total risk-weighted capital ratio |
15.63 | % | 16.56 | % | ||||
Tier 1 risk-weighted capital ratio |
14.64 | % | 15.46 | % | ||||
Common Equity Tier 1 risk-weighted capital ratio |
13.69 | % | 14.45 | % | ||||
Total capital (Common Equity Tier 1 capital + Additional Tier 1 capital + Tier 2 capital) |
¥ | 12,193.5 | ¥ | 11,983.8 | ||||
Tier 1 capital (Common Equity Tier 1 capital + Additional Tier 1 capital) |
11,415.4 | 11,186.2 | ||||||
Common Equity Tier 1 capital |
10,681.8 | 10,458.4 | ||||||
Risk-weighted assets |
77,971.4 | 72,350.1 | ||||||
The amount of minimum total capital requirements (1) |
6,237.7 | 5,788.0 | ||||||
Leverage ratio |
4.83 | % | 5.17 | % |
(1) | The amount of minimum total capital requirements is calculated by multiplying risk-weighted assets by 8%. |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In billions, except percentages) |
||||||||
SMBC Consolidated: |
||||||||
Total risk-weighted capital ratio |
14.36 | % | 15.78 | % | ||||
Tier 1 risk-weighted capital ratio |
13.31 | % | 14.53 | % | ||||
Common Equity Tier 1 risk-weighted capital ratio |
11.61 | % | 12.67 | % | ||||
Total capital (Common Equity Tier 1 capital + Additional Tier 1 capital + Tier 2 capital) |
¥ | 10,385.0 | ¥ | 10,437.1 | ||||
Tier 1 capital (Common Equity Tier 1 capital + Additional Tier 1 capital) |
9,621.4 | 9,612.8 | ||||||
Common Equity Tier 1 capital |
8,393.0 | 8,382.7 | ||||||
Risk-weighted assets |
72,286.5 | 66,120.5 | ||||||
The amount of minimum total capital requirements (1) |
5,782.9 | 5,289.6 | ||||||
Leverage ratio |
4.34 | % | 4.82 | % | ||||
SMBC Nonconsolidated: |
||||||||
Total risk-weighted capital ratio |
12.73 | % | 14.77 | % | ||||
Tier 1 risk-weighted capital ratio |
11.53 | % | 13.49 | % | ||||
Common Equity Tier 1 risk-weighted capital ratio |
9.73 | % | 11.53 | % | ||||
Total capital (Common Equity Tier 1 capital + Additional Tier 1 capital + Tier 2 capital) |
¥ | 8,544.5 | ¥ | 9,143.5 | ||||
Tier 1 capital (Common Equity Tier 1 capital + Additional Tier 1 capital) |
7,741.0 | 8,351.0 | ||||||
Common Equity Tier 1 capital |
6,531.5 | 7,141.6 | ||||||
Risk-weighted assets |
67,080.5 | 61,895.3 | ||||||
The amount of minimum total capital requirements (1) |
5,366.4 | 4,951.6 |
(1) | The amount of minimum total capital requirements is calculated by multiplying risk-weighted assets by 8%. |
• | the historical simulation method; |
• | a one-sided confidence interval of 99.0%; |
• | a one-day holding period (a one-year holding period for the strategic shareholding investment portfolio); and |
• | an observation period of four years (ten years for the strategic shareholding investment portfolio). |
Interest rate risk |
Foreign exchange risk |
Equities and commodities risk |
Others |
Total (1) |
||||||||||||||||
(In billions) |
||||||||||||||||||||
For the six months ended September 30, 2022: |
||||||||||||||||||||
SMBC Consolidated |
||||||||||||||||||||
Maximum |
¥ | 75.3 | ¥ | 73.7 | ¥ | 1.2 | ¥ | 9.5 | ¥ | 15.3 | ||||||||||
Minimum |
44.9 | 40.9 | 0.3 | 6.9 | 10.5 | |||||||||||||||
Daily average |
55.6 | 51.3 | 0.6 | 8.0 | 12.5 | |||||||||||||||
At September 30, 2022 |
54.5 | 55.0 | 0.4 | 7.0 | 12.9 | |||||||||||||||
At March 31, 2022 |
49.1 | 41.9 | 0.2 | 6.9 | 10.2 | |||||||||||||||
SMFG Consolidated |
||||||||||||||||||||
Maximum |
¥ | 84.4 | ¥ | 75.1 | ¥ | 7.1 | ¥ | 9.5 | ¥ | 31.8 | ||||||||||
Minimum |
54.3 | 42.0 | 4.3 | 6.9 | 26.2 | |||||||||||||||
Daily average |
64.9 | 52.7 | 6.1 | 8.0 | 28.4 | |||||||||||||||
At September 30, 2022 |
63.6 | 56.5 | 6.1 | 7.0 | 28.8 | |||||||||||||||
At March 31, 2022 |
59.0 | 42.7 | 5.5 | 6.9 | 25.9 |
(1) | Total for “Maximum,” “Minimum” and “Daily average” represent the maximum, minimum and daily average of the total of the trading book. For certain subsidiaries, we employ the standardized method and/or the historical simulation method for the VaR calculation method. |
Interest rate risk |
Foreign exchange risk |
Equities and commodities risk |
Others |
Total (1) |
||||||||||||||||
(In billions) |
||||||||||||||||||||
For the six months ended September 30, 2022: |
||||||||||||||||||||
SMBC Consolidated |
||||||||||||||||||||
Maximum |
¥ | 67.3 | ¥ | 0.7 | ¥ | 18.3 | ¥ | 0.0 | ¥ | 73.4 | ||||||||||
Minimum |
45.6 | 0.0 | 3.9 | 0.0 | 50.3 | |||||||||||||||
Daily average |
55.0 | 0.3 | 10.7 | 0.0 | 58.9 | |||||||||||||||
At September 30, 2022 |
52.5 | 0.5 | 5.1 | 0.0 | 55.3 | |||||||||||||||
At March 31, 2022 |
58.7 | 0.0 | 17.1 | 0.0 | 61.9 | |||||||||||||||
SMFG Consolidated |
||||||||||||||||||||
Maximum |
¥ | 68.0 | ¥ | 0.7 | ¥ | 18.3 | ¥ | 0.0 | ¥ | 74.0 | ||||||||||
Minimum |
46.6 | 0.0 | 3.9 | 0.0 | 51.2 | |||||||||||||||
Daily average |
55.8 | 0.3 | 10.7 | 0.0 | 59.7 | |||||||||||||||
At September 30, 2022 |
53.2 | 0.5 | 5.1 | 0.0 | 56.1 | |||||||||||||||
At March 31, 2022 |
59.4 | 0.0 | 17.1 | 0.0 | 62.6 |
(1) | Total for “Maximum,” “Minimum” and “Daily average” represent the maximum, minimum and daily average of the total of the banking book. |
Equities risk |
||||
(In billions) |
||||
For the six months ended September 30, 2022: |
||||
SMBC Consolidated |
||||
Maximum |
¥ | 1,047.4 | ||
Minimum |
886.2 | |||
Daily average |
968.1 | |||
At September 30, 2022 |
888.8 | |||
At March 31, 2022 |
1,043.5 | |||
SMFG Consolidated |
||||
Maximum |
¥ | 1,241.1 | ||
Minimum |
1,067.2 | |||
Daily average |
1,160.9 | |||
At September 30, 2022 |
1,070.7 | |||
At March 31, 2022 |
1,226.4 |
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||
Δ EVE |
Δ NII |
Δ EVE |
Δ NII |
|||||||||||||
(In billions) |
||||||||||||||||
SMBC Consolidated |
||||||||||||||||
Parallel shock up |
¥ | 115.0 | ¥ | (346.4 | ) | ¥ | 446.1 | ¥ | (339.4 | ) | ||||||
Parallel shock down |
4.5 | 544.9 | 3.3 | 546.6 | ||||||||||||
Steepener shock |
99.9 | — | 256.6 | — | ||||||||||||
Flattener shock |
43.3 | — | 133.2 | — | ||||||||||||
Short rate shock up |
74.3 | — | 201.2 | — | ||||||||||||
Short rate shock down |
54.1 | — | 50.9 | — | ||||||||||||
Maximum |
115.0 | 544.9 | 446.1 | 546.6 | ||||||||||||
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||
(In billions) |
||||||||||||||||
Tier 1 Capital |
¥ | 9,621.4 | ¥ | 9,612.8 | ||||||||||||
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||
Δ EVE |
Δ NII |
Δ EVE |
Δ NII |
|||||||||||||
(In billions) |
||||||||||||||||
SMFG Consolidated |
||||||||||||||||
Parallel shock up |
¥ | 115.0 | ¥ | (346.4 | ) | ¥ | 446.1 | ¥ | (339.4 | ) | ||||||
Parallel shock down |
4.5 | 544.9 | 3.3 | 546.6 | ||||||||||||
Steepener shock |
99.9 | — | 256.6 | — | ||||||||||||
Flattener shock |
43.3 | — | 133.2 | — | ||||||||||||
Short rate shock up |
74.3 | — | 201.2 | — | ||||||||||||
Short rate shock down |
54.1 | — | 50.9 | — | ||||||||||||
Maximum |
115.0 | 544.9 | 446.1 | 546.6 | ||||||||||||
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||
(In billions) |
||||||||||||||||
Tier 1 Capital |
¥ | 11,415.4 | ¥ | 11,186.2 |
Note: | ΔEVE and ΔNII are calculated by currency at the SMBC consolidated level and the results are aggregated across the various currencies. For ΔNII, only Japanese yen and U.S. dollars are included in the calculation. These are the material currencies where interest rate sensitive assets and liabilities are more than 5% of total assets and liabilities. |
Page | ||||||
F-2 |
||||||
F-3 |
||||||
F-4 |
||||||
F-5 |
||||||
F-6 |
||||||
F-7 |
||||||
1 | General Information | F-7 |
||||
2 | Summary of Significant Accounting Policies | F-7 |
||||
3 | Critical Accounting Estimates and Judgments | F-9 |
||||
4 | Segment Analysis | F-9 |
||||
5 | Derivative Financial Instruments and Hedge Accounting | F-12 | ||||
6 | Investment Securities | F-16 | ||||
7 | Loans and Advances | F-17 | ||||
8 | Borrowings | F-19 | ||||
9 | Debt Securities in Issue | F-19 | ||||
10 | Provisions | F-20 | ||||
11 | Shareholders’ Equity | F-21 | ||||
12 | Equity Attributable to Other Equity Instruments Holders | F-21 | ||||
13 | Fee and Commission Income | F-22 | ||||
14 | Impairment Charges on Financial Assets | F-23 | ||||
15 | Earnings Per Share | F-23 | ||||
16 | Dividends Per Share | F-23 | ||||
17 | Contingency and Capital Commitments | F-24 | ||||
18 | Fair Value of Financial Assets and Liabilities | F-25 | ||||
19 | Interest Rate Benchmark Reform | F-35 | ||||
20 | Events after the Statement of Financial Position Date | F-35 |
Note |
At September 30, 2022 |
At March 31, 2022 |
||||||||||
(In millions) |
||||||||||||
Assets: |
||||||||||||
Cash and deposits with banks |
¥ | ¥ | ||||||||||
Call loans and bills bought |
||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed |
||||||||||||
Trading assets |
||||||||||||
Derivative financial instruments |
5 | |||||||||||
Financial assets at fair value through profit or loss |
||||||||||||
Investment securities |
6 | |||||||||||
Loans and advances |
7 | |||||||||||
Investments in associates and joint ventures |
||||||||||||
Property, plant and equipment |
||||||||||||
Intangible assets |
||||||||||||
Other assets |
||||||||||||
Current tax assets |
||||||||||||
Deferred tax assets |
||||||||||||
|
|
|
|
|||||||||
Total assets |
¥ | ¥ | |
|||||||||
|
|
|
|
|||||||||
Liabilities: |
||||||||||||
Deposits |
¥ | ¥ | ||||||||||
Call money and bills sold |
||||||||||||
Repurchase agreements and cash collateral on securities lent |
||||||||||||
Trading liabilities |
||||||||||||
Derivative financial instruments |
5 | |||||||||||
Financial liabilities designated at fair value through profit or loss |
||||||||||||
Borrowings |
8 | |||||||||||
Debt securities in issue |
9 | |||||||||||
Provisions |
10 | |||||||||||
Other liabilities |
||||||||||||
Current tax liabilities |
||||||||||||
Deferred tax liabilities |
||||||||||||
|
|
|
|
|||||||||
Total liabilities |
||||||||||||
|
|
|
|
|||||||||
Equity: |
||||||||||||
Capital stock |
11 | |||||||||||
Capital surplus |
||||||||||||
Retained earnings |
||||||||||||
Treasury stock |
11 | ( |
) | ( |
) | |||||||
|
|
|
|
|||||||||
Equity excluding other reserves |
||||||||||||
Other reserves |
||||||||||||
|
|
|
|
|||||||||
Equity attributable to shareholders of Sumitomo Mitsui Financial Group, Inc. |
||||||||||||
Non-controlling interests |
||||||||||||
Equity attributable to other equity instruments holders |
12 | |||||||||||
|
|
|
|
|||||||||
Total equity |
||||||||||||
|
|
|
|
|||||||||
Total equity and liabilities |
¥ | ¥ | ||||||||||
|
|
|
|
For the six months ended September 30, |
||||||||||||
Note |
2022 |
2021 |
||||||||||
(In millions, except per share data) |
||||||||||||
Interest income |
¥ | |
¥ | |||||||||
Interest expense |
||||||||||||
Net interest income |
||||||||||||
Fee and commission income |
13 | |||||||||||
Fee and commission expense |
||||||||||||
Net fee and commission income |
||||||||||||
Net trading income |
||||||||||||
Net income from financial assets and liabilities at fair value through profit or loss |
||||||||||||
Net investment income (loss) |
( |
) | ||||||||||
Other income |
||||||||||||
Total operating income |
|
|||||||||||
Impairment charges on financial assets |
14 | |||||||||||
Net operating income |
||||||||||||
General and administrative expenses |
||||||||||||
Other expenses |
||||||||||||
Operating expenses |
||||||||||||
Share of post-tax profit of associates and joint ventures |
||||||||||||
Profit before tax |
||||||||||||
Income tax expense |
||||||||||||
Net profit |
¥ | ¥ | |
|||||||||
Profit attributable to: |
||||||||||||
Shareholders of Sumitomo Mitsui Financial Group, Inc. |
¥ | ¥ | ||||||||||
Non-controlling interests |
||||||||||||
Other equity instruments holders |
||||||||||||
Earnings per share: |
||||||||||||
Basic |
15 | ¥ | ¥ | |||||||||
Diluted |
15 |
For the six months ended September 30, |
||||||||||||
2022 |
2021 |
|||||||||||
(In millions) |
||||||||||||
Net profit |
¥ | ¥ | ||||||||||
Other comprehensive income: |
||||||||||||
Items that will not be reclassified to profit or loss: |
||||||||||||
Remeasurements of defined benefit plans: |
||||||||||||
Gains (losses) arising during the period, before tax |
||||||||||||
Equity instruments at fair value through other comprehensive income: |
||||||||||||
Gains (losses) arising during the period, before tax |
( |
) | ||||||||||
Own credit on financial liabilities designated at fair value through profit or loss: |
||||||||||||
Gains (losses) arising during the period, before tax |
||||||||||||
Share of other comprehensive income (loss) of associates and joint ventures |
||||||||||||
Income tax relating to items that will not be reclassified |
( |
) | ||||||||||
|
|
|
|
|||||||||
Total items that will not be reclassified to profit or loss, net of tax |
( |
) | ||||||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||
Debt instruments at fair value through other comprehensive income: |
||||||||||||
Gains (losses) arising during the period, before tax |
( |
) | ||||||||||
Reclassification adjustments for (gains) losses included in net profit, before tax |
( |
) | ||||||||||
Exchange differences on translating foreign operations: |
||||||||||||
Gains (losses) arising during the period, before tax |
||||||||||||
Reclassification adjustments for (gains) losses included in net profit, before tax |
— | |||||||||||
Share of other comprehensive income (loss) of associates and joint ventures |
||||||||||||
Income tax relating to items that may be reclassified |
||||||||||||
|
|
|
|
|||||||||
Total items that may be reclassified subsequently to profit or loss, net of tax |
||||||||||||
|
|
|
|
|||||||||
Other comprehensive income, net of tax |
||||||||||||
|
|
|
|
|||||||||
Total comprehensive income |
¥ | ¥ | ||||||||||
|
|
|
|
|||||||||
Total comprehensive income attributable to: |
||||||||||||
Shareholders of Sumitomo Mitsui Financial Group, Inc. |
¥ | ¥ | ||||||||||
Non-controlling interests |
||||||||||||
Other equity instruments holders |
Equity excluding other reserves |
Other reserves |
|||||||||||||||||||||||||||||||||||||||||||||||
Capital stock |
Capital surplus |
Retained earnings |
Treasury stock |
Remeasure- ments of defined benefit plans reserve |
Financial instruments at fair value through other comprehensive income reserve |
Own credit on financial liabilities designated at fair value through profit or loss reserve |
Exchange differences on translating foreign operations reserve |
Equity attributable to SMFG’s shareholders |
Non- controlling interests |
Equity attributable to other equity instruments holders |
Total equity |
|||||||||||||||||||||||||||||||||||||
(In millions) |
||||||||||||||||||||||||||||||||||||||||||||||||
Balance at April 1, 2021 |
¥ | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||||||
Net profit |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | ( |
) | — | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total comprehensive income |
— | — | — | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Issuance of shares under share-based payment transactions |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Acquisition and disposal of subsidiaries and |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Transaction with non-controlling interest shareholders |
— | ( |
) | — | — | — | — | — | — | ( |
) | — | ||||||||||||||||||||||||||||||||||||
Share of changes in capital surplus of associates and joint ventures |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Dividends to shareholders |
— | — | ( |
) | — | — | — | — | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||
Coupons on other equity instruments |
— | — | — | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
Purchases of other equity instruments and sales of other equity instruments-net |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Purchases of treasury stock |
— | — | — | ( |
) | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Sales of treasury stock |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Loss on sales of treasury stock |
— | — | ( |
) | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Share-based payment transactions |
— | ( |
) | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Transfer from other reserves to retained earnings |
— | — | — | ( |
) | ( |
) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Others |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Balance at September 30, 2021 |
¥ | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Balance at April 1, 2022 |
¥ | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||||||
Net profit |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | ( |
) | — | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total comprehensive income |
— | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Issuance of shares under share-based payment transactions |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Transaction with non-controlling interest shareholders |
— | ( |
) | — | — | — | — | — | — | ( |
) | — | ||||||||||||||||||||||||||||||||||||
Dividends to shareholders |
— | — | ( |
) | — | — | — | — | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||
Coupons on other equity instruments |
— | — | — | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
Purchases of other equity instruments and sales of other equity instruments-net |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Purchases of treasury stock |
— | — | — | ( |
) | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Sales of treasury stock |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Loss on sales of treasury stock |
— | — | ( |
) | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Share-based payment transactions |
— | ( |
) | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||
Transfer from other reserves to retained earnings |
— | — | — | ( |
) | ( |
) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Others |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Balance at September 30, 2022 |
¥ | ¥ | ¥ | ¥ | ( |
) | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Operating Activities: |
||||||||
Profit before tax |
¥ | ¥ | ||||||
Adjustments for: |
||||||||
Gains on financial assets at fair value through profit or loss and investment securities |
( |
) | ( |
) | ||||
Foreign exchange (gains) losses |
( |
) | ||||||
Provision for loan losses |
||||||||
Depreciation and amortization |
||||||||
Share of post-tax profit of associates and joint ventures |
( |
) | ( |
) | ||||
Net changes in assets and liabilities: |
||||||||
Net (increase) decrease of term deposits with original maturities over three months |
( |
) | ||||||
Net increase of call loans and bills bought |
( |
) | ( |
) | ||||
Net decrease of reverse repurchase agreements and cash collateral on securities borrowed |
||||||||
Net increase of loans and advances |
( |
) | ( |
) | ||||
Net change of trading assets and liabilities, derivative financial instruments, and financial liabilities designated at fair value through profit or loss |
( |
) | ||||||
Net increase (decrease) of deposits |
( |
) | ||||||
Net increase of call money and bills sold |
||||||||
Net decrease of repurchase agreements and cash collateral on securities lent |
( |
) | ( |
) | ||||
Net increase (decrease) of other unsubordinated borrowings and debt securities in issue |
( |
) | ||||||
Income taxes paid—net |
( |
) | ( |
) | ||||
Other operating activities—net |
( |
) | ||||||
|
|
|
|
|||||
Net cash and cash equivalents used in operating activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Investing Activities: |
||||||||
Purchases of financial assets at fair value through profit or loss and investment securities |
( |
) | ( |
) | ||||
Proceeds from sales of financial assets at fair value through profit or loss and investment securities |
||||||||
Proceeds from maturities of financial assets at fair value through profit or loss and investment securities |
||||||||
Investments in associates and joint ventures |
— |
( |
) | |||||
Proceeds from sales of investments in associates and joint ventures |
||||||||
Purchases of property, plant and equipment, and investment properties |
( |
) | ( |
) | ||||
Purchases of intangible assets |
( |
) | ( |
) | ||||
Proceeds from sales of property, plant and equipment, investment properties and intangible assets |
||||||||
|
|
|
|
|||||
Net cash and cash equivalents provided by investing activities |
||||||||
|
|
|
|
|||||
Financing Activities: |
||||||||
Redemption of subordinated borrowings |
|
|
( |
) |
|
|
— |
|
Proceeds from issuance of subordinated bonds |
— |
|||||||
Redemption of subordinated bonds |
— |
( |
) | |||||
Payments for the principal portion of lease liabilities |
( |
) | ( |
) | ||||
Dividends paid to shareholders of Sumitomo Mitsui Financial Group, Inc. |
( |
) | ( |
) | ||||
Dividends paid to non-controlling interest shareholders |
( |
) | ( |
) | ||||
Coupons paid to other equity instruments holders |
( |
) | ( |
) | ||||
Purchases of treasury stock and proceeds from sales of treasury stock—net |
||||||||
Purchases of other equity instruments and proceeds from sales of other equity instruments—net |
||||||||
Transactions with non-controlling interest shareholders—net |
||||||||
|
|
|
|
|||||
Net cash and cash equivalents used in financing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents |
||||||||
|
|
|
|
|||||
Net decrease of cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents at beginning of period |
||||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
¥ | ¥ | ||||||
|
|
|
|
|||||
Net cash and cash equivalents provided by operating activities includes: |
||||||||
Interest and dividends received |
¥ | ¥ | ||||||
Interest paid |
1 |
GENERAL INFORMATION |
2 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
3 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS |
4 |
SEGMENT ANALYSIS |
Wholesale Business Unit |
Retail Business Unit |
Global Business Unit |
Global Markets Business Unit |
Head office account and others |
Total |
|||||||||||||||||||
(In billions) |
||||||||||||||||||||||||
Consolidated gross profit (1) |
¥ |
¥ |
¥ |
¥ |
¥ |
( |
) | ¥ |
||||||||||||||||
General and administrative expenses |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Others (2) |
( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Consolidated net business profit |
¥ |
¥ |
¥ |
¥ |
¥ |
( |
) | ¥ |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
For the six months ended September 30, 2021: |
| |||||||||||||||||||||||
Wholesale Business Unit |
Retail Business Unit |
Global Business Unit |
Global Markets Business Unit |
Head office account and others |
Total |
|||||||||||||||||||
(In billions) |
||||||||||||||||||||||||
Consolidated gross profit (1) |
¥ |
¥ |
¥ |
¥ |
¥ |
( |
) |
¥ |
||||||||||||||||
General and administrative expenses |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Others (2) |
( |
) |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Consolidated net business profit |
¥ |
¥ |
¥ |
¥ |
¥ |
( |
) |
¥ |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Consolidated gross profit = (Interest income – Interest expenses) + Trust fees + (Fee and commission income – Fee and commission expenses) + (Trading income – Trading losses) + (Other operating income – Other operating expenses). |
(2) | “Others” includes share of profit or loss of equity-method associates and joint ventures and cooperated profit and loss, that is, profit and loss double counted within the Group’s business segments in the managerial accounting. |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In billions) |
||||||||
Consolidated net business profit |
¥ | |
¥ | |||||
Differences between management reporting and Japanese GAAP: |
||||||||
Total credit costs |
( |
) |
( |
) | ||||
Gains on equity instruments |
||||||||
Extraordinary gains or losses and others |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Profit before tax under Japanese GAAP |
||||||||
|
|
|
|
|||||
Differences between Japanese GAAP and IFRS: |
||||||||
Scope of consolidation |
||||||||
Derivative financial instruments |
( |
) | ||||||
Investment securities |
( |
) | ( |
) | ||||
Loans and advances |
( |
) | ||||||
Investments in associates and joint ventures |
( |
) | ( |
) | ||||
Property, plant and equipment |
( |
) | ||||||
Lease accounting |
— | ( |
) | |||||
Defined benefit plans |
( |
) | ( |
) | ||||
Foreign currency translation |
( |
) | ( |
) | ||||
Classification of equity and liability |
||||||||
Others |
||||||||
|
|
|
|
|||||
Profit before tax under IFRS |
¥ | ¥ | ||||||
|
|
|
|
5 |
DERIVATIVE FINANCIAL INSTRUMENTS AND HEDGE ACCOUNTING |
At September 30, 2022 |
||||||||||||||||||||||||
Trading |
Risk Management (1) |
|||||||||||||||||||||||
Notional amounts |
Assets |
Liabilities |
Notional amounts |
Assets |
Liabilities |
|||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Interest rate derivatives |
¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||
Futures |
||||||||||||||||||||||||
Listed Options |
— | — | — | |||||||||||||||||||||
Forwards |
— | — | — | |||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
OTC Options |
— | |||||||||||||||||||||||
Currency derivatives |
||||||||||||||||||||||||
Futures |
— | — | — | — | ||||||||||||||||||||
Listed Options |
— | — | — | — | — | — | ||||||||||||||||||
Forwards |
||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Equity derivatives |
— | — | — | |||||||||||||||||||||
Futures |
— | — | — | |||||||||||||||||||||
Listed Options |
— | — | — | |||||||||||||||||||||
Forwards |
— | — | — | — | ||||||||||||||||||||
Swaps |
— | — | — | |||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Commodity derivatives |
— | — | — | |||||||||||||||||||||
Futures |
— | — | — | |||||||||||||||||||||
Listed Options |
— | — | — | — | — | — | ||||||||||||||||||
Forwards |
— | — | — | — | — | — | ||||||||||||||||||
Swaps |
— | — | — | |||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Credit derivatives |
— | — | — | |||||||||||||||||||||
Total derivative financial instruments |
¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||
At March 31, 2022 |
||||||||||||||||||||||||
Trading |
Risk Management (1) |
|||||||||||||||||||||||
Notional amounts |
Assets |
Liabilities |
Notional amounts |
Assets |
Liabilities |
|||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Interest rate derivatives |
¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||
Futures |
||||||||||||||||||||||||
Listed Options |
— | — | — | |||||||||||||||||||||
Forwards |
— | — | — | |||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
OTC Options |
— | |||||||||||||||||||||||
Currency derivatives |
||||||||||||||||||||||||
Futures |
— | — | — | |||||||||||||||||||||
Listed Options |
— | — | — | — | — | — | ||||||||||||||||||
Forwards |
||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Equity derivatives |
— | |||||||||||||||||||||||
Futures |
— | — | — | |||||||||||||||||||||
Listed Options |
— | — | — | |||||||||||||||||||||
Forwards |
— | — | — | — | — | — | ||||||||||||||||||
Swaps |
— | |||||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Commodity derivatives |
— | — | — | |||||||||||||||||||||
Futures |
— | — | — | |||||||||||||||||||||
Listed Options |
— | — | — | — | — | — | ||||||||||||||||||
Forwards |
— | — | — | — | — | — | ||||||||||||||||||
Swaps |
— | — | — | |||||||||||||||||||||
OTC Options |
— | — | — | |||||||||||||||||||||
Credit derivatives |
— | — | — | |||||||||||||||||||||
Total derivative financial instruments |
¥ | ¥ | ¥ | ¥ | ¥ | ¥ | ||||||||||||||||||
(1) | Derivative financial instruments categorized as “Risk Management” are used for economic hedging, such as managing the exposure to changes in fair value of the loan portfolio, and are identified as hedging instruments under Japanese GAAP. Under IFRS, the Group applies hedge accounting for certain fixed rate debt securities in issue, borrowings and debt instruments at fair value through other comprehensive income (“FVOCI”), certain equity instruments elected to be measured at FVOCI and net investments in foreign operations. Derivative financial instruments designated as hedging instruments are also categorized as “Risk Management.” |
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||||||||||
Notional amounts |
Carrying amounts |
Notional amounts |
Carrying amounts |
|||||||||||||||||||||
Assets |
Liabilities |
Assets |
Liabilities |
|||||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||||
Interest rate swaps |
¥ | |
¥ | |
¥ | |
¥ | |
¥ | ¥ | |
|||||||||||||
Interest rate options |
— |
— | ||||||||||||||||||||||
Stock price risk |
||||||||||||||||||||||||
Equity swaps |
— |
— |
— |
— |
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||||||||||
Nominal amounts |
Carrying amounts |
Nominal amounts |
Carrying amounts |
|||||||||||||||||||||
Assets |
Liabilities |
Assets |
Liabilities |
|||||||||||||||||||||
(In millions) |
||||||||||||||||||||||||
Foreign exchange forward contracts |
¥ | |
¥ | |
¥ | |
¥ | |
¥ | ¥ | |
|||||||||||||
Foreign currency denominated financial liabilities |
— | — |
6 |
INVESTMENT SECURITIES |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Debt instruments at amortized cost: |
||||||||
Domestic: |
||||||||
Japanese government bonds |
¥ | ¥ | — | |||||
Japanese municipal bonds |
||||||||
Total domestic |
||||||||
Foreign: |
||||||||
Bonds issued by other governments and official institutions (1) |
||||||||
Other debt instruments |
||||||||
Total foreign |
||||||||
Total debt instruments at amortized cost |
¥ | ¥ | ||||||
Debt instruments at fair value through other comprehensive income: |
||||||||
Domestic: |
||||||||
Japanese government bonds |
¥ | ¥ | ||||||
Japanese municipal bonds |
||||||||
Japanese corporate bonds |
||||||||
Other debt instruments |
||||||||
Total domestic |
||||||||
Foreign: |
||||||||
U.S. Treasury and other U.S. government agency bonds |
||||||||
Bonds issued by other governments and official institutions (1) |
||||||||
Mortgage-backed securities |
||||||||
Other debt instruments |
||||||||
Total foreign |
||||||||
Total debt instruments at fair value through other comprehensive income |
¥ | ¥ | ||||||
Equity instruments at fair value through other comprehensive income: |
||||||||
Domestic equity instruments |
¥ | ¥ | ||||||
Foreign equity instruments |
||||||||
Total equity instruments at fair value through other comprehensive income |
¥ | ¥ | ||||||
Total investment securities |
¥ | ¥ | ||||||
(1) | Bonds issued by governments and official institutions excluding U.S. Treasury and other U.S. government agencies. |
7 |
LOANS AND ADVANCES |
At September 30, 2022 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Loans and advances at amortized cost: |
||||||||||||||||
Gross loans and advances |
¥ | ¥ | ¥ | ¥ | ||||||||||||
Adjust: Unearned income, unamortized premiums—net and deferred loan fees—net |
( |
) | ||||||||||||||
Less: Allowance for loan losses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Carrying amount |
¥ | |||||||||||||||
At March 31, 2022 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Loans and advances at amortized cost: |
||||||||||||||||
Gross loans and advances |
¥ | ¥ | ¥ | ¥ | ||||||||||||
Adjust: Unearned income, unamortized premiums—net and deferred loan fees—net |
( |
) | ||||||||||||||
Less: Allowance for loan losses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Carrying amount |
¥ | |||||||||||||||
At September 30, 2022 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Allowance for loan losses: |
||||||||||||||||
Balance at April 1, 2022 |
¥ |
¥ |
¥ |
¥ |
||||||||||||
Net transfers between stages |
( |
) | ( |
) | — |
|||||||||||
Provision for loan losses |
||||||||||||||||
Charge-offs (1) |
— |
— |
||||||||||||||
Recoveries |
— |
— |
||||||||||||||
Net charge-offs |
— |
— |
||||||||||||||
Others (2) |
||||||||||||||||
Balance at September 30, 2022 |
¥ |
¥ |
¥ |
¥ |
||||||||||||
At September 30, 2021 |
||||||||||||||||
12-month ECL |
Lifetime ECL not credit- impaired |
Lifetime ECL credit-impaired |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Allowance for loan losses: |
||||||||||||||||
Balance at April 1, 2021 |
¥ |
¥ |
¥ |
¥ |
||||||||||||
Net transfers between stages |
( |
) | ( |
) | — |
|||||||||||
Provision (credit) for loan losses |
( |
) | ( |
) | ||||||||||||
Charge-offs (1) |
— |
— |
||||||||||||||
Recoveries |
— |
— |
||||||||||||||
Net charge-offs |
— |
— |
||||||||||||||
Others (2) |
||||||||||||||||
Balance at September 30, 2021 |
¥ |
¥ |
¥ |
¥ |
||||||||||||
(1) | Charge-offs consist of the reduction of the allowance through the sales of loans and write-offs. |
(2) | Others mainly include foreign exchange translations for the six months ended September 30, 2022 and 2021. |
For the fiscal year ending March 31, |
||||||||
2023 |
2024 |
|||||||
(%) |
||||||||
Japanese GDP |
||||||||
Global GDP |
8 |
BORROWINGS |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Unsubordinated borrowings |
¥ |
¥ |
||||||
Subordinated borrowings |
||||||||
Liabilities associated with securitization transactions |
||||||||
Lease liabilities |
||||||||
Total borrowings |
¥ |
¥ |
||||||
9 |
DEBT SECURITIES IN ISSUE |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Commercial paper |
¥ |
¥ |
||||||
Unsubordinated bonds |
||||||||
Subordinated bonds |
||||||||
Total debt securities in issue |
¥ |
¥ |
||||||
10 |
PROVISIONS |
Provision for interest repayment |
Other provisions |
Total |
||||||||||
(In millions) |
||||||||||||
Balance at April 1, 2022 |
¥ | ¥ | ¥ | |||||||||
Additional provisions |
||||||||||||
Amounts used |
( |
) |
( |
) | ( |
) | ||||||
Unused amounts reversed |
( |
) |
( |
) | ||||||||
Amortization of discount and effect of change in discount rate |
( |
) | ||||||||||
Others |
||||||||||||
Balance at September 30, 2022 |
¥ | ¥ | ¥ | |||||||||
11 |
SHAREHOLDERS’ EQUITY |
At September 30, 2022 |
At March 31, 2022 |
|||||||
Shares outstanding |
||||||||
Shares in treasury |
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||
Authorized |
Issued |
Authorized |
Issued |
|||||||||||||
Type 5 preferred stock |
— | — | ||||||||||||||
Type 7 preferred stock |
— | — | ||||||||||||||
Type 8 preferred stock |
— | — | ||||||||||||||
Type 9 preferred stock |
— | — |
12 |
EQUITY ATTRIBUTABLE TO OTHER EQUITY INSTRUMENTS HOLDERS |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Perpetual subordinated bonds |
¥ |
¥ |
||||||
Total equity attributable to other equity instruments holders |
¥ |
¥ |
||||||
13 |
FEE AND COMMISSION INCOME |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Loans |
¥ |
¥ |
||||||
Credit card business |
||||||||
Guarantees |
||||||||
Securities-related business |
||||||||
Deposits |
||||||||
Remittances and transfers |
||||||||
Safe deposits |
||||||||
Trust fees |
||||||||
Investment trusts |
||||||||
Agency |
||||||||
Others |
||||||||
Total fee and commission income |
¥ |
¥ |
||||||
14 |
IMPAIRMENT CHARGES ON FINANCIAL ASSETS |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Loans and advances |
¥ | ¥ | ||||||
Loan commitments |
( |
) |
||||||
Financial guarantees |
( |
) | ||||||
Total impairment charges on financial assets |
¥ | |
¥ | |
||||
15 |
EARNINGS PER SHARE |
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions, except number of shares and per share data) |
||||||||
Basic: |
||||||||
Profit attributable to shareholders of the Company |
¥ | ¥ | ||||||
Weighted average number of common stock in issue (in thousands of shares) |
||||||||
|
|
|
|
|||||
Basic earnings per share |
¥ | ¥ | ||||||
Diluted: |
||||||||
Profit attributable to the common shareholders of the Company |
¥ | ¥ | ||||||
Impact of dilutive potential ordinary shares issued by subsidiaries |
||||||||
|
|
|
|
|||||
Net profit used to determine diluted earnings per share |
¥ | ¥ | ||||||
|
|
|
|
|||||
Weighted average number of common stock in issue (in thousands of shares) |
||||||||
Adjustments for stock options (in thousands of shares) |
||||||||
|
|
|
|
|||||
Weighted average number of common stock for diluted earnings per share (in thousands of shares) |
||||||||
|
|
|
|
|||||
Diluted earnings per share |
¥ | |
¥ |
16 |
DIVIDENDS PER SHARE |
Per share |
Aggregate amount |
|||||||
(In yen) |
(In millions) |
|||||||
Dividends on common stock for the six months ended September 30, |
||||||||
2022 |
¥ | ¥ | ||||||
2021 |
¥ | ¥ |
17 |
CONTINGENCY AND CAPITAL COMMITMENTS |
At September 30, 2022 |
At March 31, 2022 |
|||||||
(In millions) |
||||||||
Loan commitments |
¥ | ¥ | ||||||
Financial guarantees and other credit-related contingent liabilities |
||||||||
|
|
|
|
|||||
Total |
¥ | ¥ | ||||||
|
|
|
|
18 |
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES |
• | quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date (Level 1); |
• | inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (Level 2); and |
• | significant unobservable inputs for the asset or liability (Level 3). |
At September 30, 2022 |
||||||||||||||||
Level 1 (1) |
Level 2 (1) |
Level 3 |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Financial assets: |
||||||||||||||||
Trading assets: |
||||||||||||||||
Debt instruments |
¥ | ¥ | ¥ | — | ¥ | |||||||||||
Equity instruments |
— | |||||||||||||||
Total trading assets |
— | |||||||||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
||||||||||||||||
Currency derivatives |
— | |||||||||||||||
Equity derivatives |
||||||||||||||||
Commodity derivatives |
— | |||||||||||||||
Credit derivatives |
— | |||||||||||||||
Total derivative financial instruments |
||||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||
Debt instruments |
||||||||||||||||
Equity instruments |
||||||||||||||||
Total financial assets at fair value through profit or loss |
||||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||
Japanese government bonds |
— | — | ||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
— | — | ||||||||||||||
Other debt instruments |
— | |||||||||||||||
Total debt instruments |
— | |||||||||||||||
Equity instruments |
||||||||||||||||
Total investment securities at fair value through other comprehensive income |
||||||||||||||||
Total |
¥ | ¥ | ¥ | ¥ | ||||||||||||
Financial liabilities: |
||||||||||||||||
Trading liabilities: |
||||||||||||||||
Debt instruments |
¥ | ¥ | ¥ | — | ¥ | |||||||||||
Equity instruments |
— | |||||||||||||||
Total trading liabilities |
— | |||||||||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
||||||||||||||||
Currency derivatives |
||||||||||||||||
Equity derivatives |
||||||||||||||||
Commodity derivatives |
— | |||||||||||||||
Credit derivatives |
— | |||||||||||||||
Total derivative financial instruments |
||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
— | |||||||||||||||
Others (2) |
— | ( |
) |
( |
) |
( |
) | |||||||||
Total |
¥ | ¥ | ¥ | ¥ | ||||||||||||
At March 31, 2022 |
||||||||||||||||
Level 1 (1) |
Level 2 (1) |
Level 3 |
Total |
|||||||||||||
(In millions) |
||||||||||||||||
Financial assets: |
||||||||||||||||
Trading assets: |
||||||||||||||||
Debt instruments |
¥ | ¥ | ¥ | — | ¥ | |||||||||||
Equity instruments |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total trading assets |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
||||||||||||||||
Currency derivatives |
||||||||||||||||
Equity derivatives |
||||||||||||||||
Commodity derivatives |
— | |||||||||||||||
Credit derivatives |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total derivative financial instruments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||
Debt instruments |
||||||||||||||||
Equity instruments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial assets at fair value through profit or loss |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||
Japanese government bonds |
— | — | ||||||||||||||
U.S. Treasury and other U.S. government agency bonds |
— | — | ||||||||||||||
Other debt instruments |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total debt instruments |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Equity instruments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total investment securities at fair value through other comprehensive income |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
¥ | ¥ | ¥ | ¥ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial liabilities: |
||||||||||||||||
Trading liabilities: |
||||||||||||||||
Debt instruments |
¥ | ¥ | ¥ | — | ¥ | |||||||||||
Equity instruments |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total trading liabilities |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
||||||||||||||||
Currency derivatives |
||||||||||||||||
Equity derivatives |
||||||||||||||||
Commodity derivatives |
— | |||||||||||||||
Credit derivatives |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total derivative financial instruments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial liabilities designated at fair value through profit or loss |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Others (2) (3) |
— | ( |
) | ( |
) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
¥ | ¥ | ¥ | ¥ | ||||||||||||
|
|
|
|
|
|
|
|
(1) | Transfers between levels of the fair value hierarchy are deemed to have occurred at the beginning of the period. There were no significant transfers between Level 1 and Level 2 for the six months ended September 30, 2022 and for the fiscal year ended March 31, 2022. |
(2) | Derivatives embedded in financial liabilities, except for financial liabilities designated at fair value through profit or loss, are separately accounted for, but presented together with the host contract in the consolidated statements of financial position. In these tables, the separated embedded derivatives whose host contracts are carried at amortized cost are presented within others. Although the separated embedded derivatives may have a positive or a negative fair value, they have been presented in these tables as liabilities to be consistent with the host contract. The separated embedded derivatives are measured at fair value using the valuation techniques described in “Derivative financial instruments (including embedded derivatives)” in Note 44 “Fair Value of Financial Assets and Liabilities” of the Group’s consolidated financial statements for the fiscal year ended March 31, 2022. |
(3) | Contingent consideration liabilities arising from business combinations, which are measured at fair value using discounted cash flow models, are presented as others. |
Total gains (losses) |
Changes in unrealized gains (losses) included in profit or loss related to assets and liabilities held at September 30, 2022 |
|||||||||||||||||||||||||||||||||||||||||||
At April 1, 2022 |
Included in profit or loss |
Included in other comprehensive income |
Purchases |
Sales |
Issuances |
Settlements (1) |
Transfers into Level 3 (2) |
Transfers out of Level 3 (2) |
At September 30, 2022 |
|||||||||||||||||||||||||||||||||||
(In millions) |
||||||||||||||||||||||||||||||||||||||||||||
Derivative financial instruments—net: |
||||||||||||||||||||||||||||||||||||||||||||
Interest rate derivatives—net |
¥ |
( |
) |
¥ |
( |
) | ¥ |
— |
¥ |
¥ |
— |
¥ |
— |
¥ |
— |
¥ |
— |
¥ |
— |
¥ |
( |
) | ¥ |
( |
) | |||||||||||||||||||
Currency derivatives—net |
( |
) | — |
— |
— |
— |
— |
— |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Equity derivatives—net |
— |
( |
) | — |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||
Credit derivatives—net |
( |
) | — |
— |
— |
— |
— |
— |
— |
( |
) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total derivative financial instruments—net |
( |
) |
— |
( |
) | — |
— |
— |
( |
) | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||||||||||||||||||||||||||||||
Debt instruments |
( |
) | — |
( |
) | — |
( |
) | ||||||||||||||||||||||||||||||||||||
Equity instruments |
— |
( |
) | — |
( |
) | — |
( |
) | ( |
) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total financial assets at fair value through profit or loss |
( |
) | — |
( |
) | — |
( |
) | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||
Equity instruments |
— |
( |
) | ( |
) | — |
( |
) |
— |
— |
— |
|||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total investment securities at fair value through other comprehensive income |
— |
( |
) |
( |
) | — |
( |
) | — |
— |
— |
|||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
( |
) |
— |
— |
( |
) | — |
— |
( |
) |
||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Others (3) —liabilities |
— |
— |
— |
— |
— |
( |
) |
|||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total |
¥ |
¥ |
¥ |
( |
) | ¥ |
¥ |
( |
) |
¥ |
( |
) |
¥ |
¥ |
— |
¥ |
( |
) |
¥ |
¥ |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gains (losses) |
Changes in unrealized gains (losses) included in profit or loss related to assets and liabilities held at September 30, 2021 |
|||||||||||||||||||||||||||||||||||||||||||
At April 1, 2021 |
Included in profit or loss |
Included in other comprehensive income |
Purchases |
Sales |
Issuances |
Settlements (1) |
Transfers into Level 3 (2) |
Transfers out of Level 3 (2) |
At September 30, 2021 |
|||||||||||||||||||||||||||||||||||
(In millions) |
||||||||||||||||||||||||||||||||||||||||||||
Derivative financial instruments—net: |
||||||||||||||||||||||||||||||||||||||||||||
Interest rate derivatives—net |
¥ | ( |
) | ¥ | ¥ | — | ¥ | ¥ | — | ¥ | — | ¥ | — | ¥ | — | ¥ | ( |
) | ¥ | ( |
) | ¥ | ||||||||||||||||||||||
Currency derivatives—net |
( |
) | — | — | — | — | — | — | ( |
) | ||||||||||||||||||||||||||||||||||
Equity derivatives—net |
( |
) | — | ( |
) | — | — | — | — | |||||||||||||||||||||||||||||||||||
Credit derivatives—net |
— | ( |
) | — | — | |||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total derivative financial instruments—net |
( |
) | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||||||||||||||||||||||||||||||
Debt instruments |
( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||||||
Equity instruments |
( |
) | — | ( |
) | — | ( |
) | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total financial assets at fair value through profit or loss |
( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||
Equity instruments |
— | ( |
) | — | ( |
) | — | ( |
) | — | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total investment securities at fair value through other comprehensive income |
— | ( |
) | — | ( |
) | — | ( |
) | — | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Others (3) —liabilities |
( |
) | ( |
) | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total |
¥ | ¥ | ¥ | ¥ | ¥ | ( |
) | ¥ | ( |
) | ¥ | ¥ | — | ¥ | ¥ | ¥ | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Settlements for equity instruments include redemption of preferred stocks and receipt of cash distributions which represent a return of investment. |
(2) | Transfers between levels of the fair value hierarchy are deemed to have occurred at the beginning of the period. For the six months ended September 30, 2022, transfers out of Level 3 amounted to ¥million primarily due to a decrease of significance of unobservable inputs of certain financial assets at fair value through profit or loss, including ¥(certain investment funds. On the other hand, for the six months ended September 30, 2021, those amounted tomillion primarily due to an increase in observability of inputs for certain financial liabilities designated at fair value through profit or loss. |
(3) | Derivatives embedded in financial liabilities, except for financial liabilities designated at fair value through profit or loss, are separately accounted for, but presented together with the host contract in the consolidated statements of financial position. In these tables, the separated embedded derivatives whose host contracts are carried at amortized cost are presented within others. Although the separated embedded derivatives may have a positive or a negative fair value, they have been presented in these tables as liabilities to be consistent with the host contract. |
Total gains (losses) included in profit or loss for the six months ended September 30, |
Changes in unrealized gains (losses) included in profit or loss related to assets and liabilities held at September 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
(In millions) |
||||||||||||||||
Net interest income |
¥ | ¥ | ¥ | ¥ | ||||||||||||
Net trading income (loss) |
( |
) | ||||||||||||||
Net income from financial assets and liabilities at fair value profit or loss |
||||||||||||||||
Other expenses |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
¥ | ¥ | ¥ | ¥ | ||||||||||||
|
|
|
|
|
|
|
|
For the six months ended September 30, |
||||||||
2022 |
2021 |
|||||||
(In millions) |
||||||||
Balance at beginning of period |
¥ | ¥ | ||||||
Increase due to new trades |
||||||||
Reduction due to redemption, sales or passage of time |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Balance at end of period |
¥ | ¥ | ||||||
|
|
|
|
At September 30, 2022 |
||||||||||||||||
Assets |
Liabilities |
Valuation technique(s) (1) |
Significant unobservable inputs (1) |
Range of inputs (1) |
||||||||||||
(In millions) |
||||||||||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
¥ |
¥ |
Option model |
Interest rate to interest rate correlation |
||||||||||||
Quanto correlation |
||||||||||||||||
Currency derivatives |
Option model |
Interest rate to interest rate correlation |
||||||||||||||
Quanto correlation |
||||||||||||||||
Foreign exchange volatility |
||||||||||||||||
Equity derivatives |
Option model |
Equity to equity correlation |
||||||||||||||
Quanto correlation |
( |
|||||||||||||||
Equity volatility |
||||||||||||||||
Credit derivatives |
Credit Default model |
Quanto correlation |
||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||
Debt instruments |
— |
Option model |
Foreign exchange volatility |
|||||||||||||
DCF model |
Probability of default rate |
|||||||||||||||
Loss given default rate |
||||||||||||||||
Net asset value (2) |
— |
— |
||||||||||||||
Equity instruments |
— |
DCF model |
Probability of default rate |
|||||||||||||
Loss given default rate |
||||||||||||||||
See note (3) below |
— |
— |
||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||
Equity instruments |
— |
Market multiples |
Price/ Book value multiple |
|||||||||||||
Liquidity discount |
||||||||||||||||
See note (3) below |
— |
— |
||||||||||||||
Financial liabilities designated at fair value through profit or loss |
Option model |
Equity to equity correlation |
||||||||||||||
Interest rate to interest rate correlation |
||||||||||||||||
Quanto correlation |
( |
|||||||||||||||
Equity volatility |
||||||||||||||||
Credit Default model |
Quanto correlation |
|||||||||||||||
Others (4) |
( |
) |
Option model |
Equity to equity correlation |
||||||||||||
Interest rate to interest rate correlation |
||||||||||||||||
Quanto correlation |
||||||||||||||||
Equity volatility |
||||||||||||||||
Foreign exchange volatility |
||||||||||||||||
Credit Default model |
Quanto correlation |
At March 31, 2022 |
||||||||||||||||
Assets |
Liabilities |
Valuation technique(s) (1) |
Significant unobservable inputs (1) |
Range of inputs (1) |
||||||||||||
(In millions) |
||||||||||||||||
Derivative financial instruments: |
||||||||||||||||
Interest rate derivatives |
¥ |
¥ |
Option model |
Interest rate to interest rate correlation |
||||||||||||
Quanto correlation |
||||||||||||||||
Currency derivatives |
Option model |
Interest rate to interest rate correlation |
||||||||||||||
Quanto correlation |
||||||||||||||||
Foreign exchange volatility |
||||||||||||||||
DCF model |
Prepayment rate |
|||||||||||||||
Equity derivatives |
Option model |
Equity to equity correlation |
||||||||||||||
Quanto correlation |
( |
|||||||||||||||
Equity volatility |
||||||||||||||||
Credit derivatives |
Credit Default model |
Quanto correlation |
||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||
Debt instruments |
— |
Monte Carlo Simulation |
Equity volatility |
|||||||||||||
Option model |
Foreign exchange volatility |
|||||||||||||||
DCF model |
Probability of default rate |
|||||||||||||||
Loss given default rate |
||||||||||||||||
Net asset value (2) |
— |
— |
||||||||||||||
Equity instruments |
— |
DCF model |
Probability of default rate |
|||||||||||||
Loss given default rate |
||||||||||||||||
See note (3) below |
— |
— |
||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||
Equity instruments |
— |
Market multiples |
Price/Earnings multiple |
|||||||||||||
Price/Book value multiple |
||||||||||||||||
EV/EBITDA multiple |
||||||||||||||||
Liquidity discount |
||||||||||||||||
See note (3) below |
— |
— |
||||||||||||||
Financial liabilities designated at fair value through profit or loss |
Option model |
Equity to equity correlation |
||||||||||||||
Interest rate to interest rate correlation |
||||||||||||||||
Quanto correlation |
( |
|||||||||||||||
Equity volatility |
||||||||||||||||
Credit Default model |
Quanto correlation |
|||||||||||||||
Others (4) |
( |
) |
Option model |
Equity to equity correlation |
||||||||||||
Interest rate to interest rate correlation |
||||||||||||||||
Quanto correlation |
||||||||||||||||
Equity volatility |
||||||||||||||||
Foreign exchange volatility |
||||||||||||||||
Credit Default model |
Quanto correlation |
(1) | Valuation techniques and unobservable inputs for insignificant Level 3 financial assets and liabilities are excluded. |
(2) | The Group has determined that the net asset value represents fair values of certain investment funds. |
(3) | Fair values of certain equity instruments such as unlisted stocks are estimated on the basis of an analysis of the investee’s financial position and results, risk profile, prospects and other factors. A range of key inputs is not provided in these tables as it is not practical to do so given the nature of such valuation techniques. |
(4) | Derivatives embedded in financial liabilities, except for financial liabilities designated at fair value through profit or loss, are separately accounted for, but presented together with the host contract in the consolidated statements of financial position. In these tables, the separated embedded derivatives whose host contracts are carried at amortized cost are presented within others. Although the separated embedded derivatives may have a positive or a negative fair value, they have been presented in these tables as liabilities to be consistent with the host contract. |
At September 30, 2022 |
||||||||||||||||||||
Total fair value measured using valuation techniques |
Effect recorded in profit or loss |
Effect recorded directly in equity |
||||||||||||||||||
Favorable changes |
Unfavorable changes |
Favorable changes |
Unfavorable changes |
|||||||||||||||||
(In millions) |
||||||||||||||||||||
Financial instruments—net: |
||||||||||||||||||||
Derivative financial instruments—net: |
||||||||||||||||||||
Interest rate derivatives—net |
¥ | ( |
) |
¥ | — | ¥ | — | ¥ | — | ¥ | — | |||||||||
Currency derivatives—net |
( |
) | — | — | ||||||||||||||||
Equity derivatives—net |
— | — | ||||||||||||||||||
Credit derivatives—net |
— | — | ||||||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||||||
Debt instruments |
— | — | ||||||||||||||||||
Equity instruments |
— | — | ||||||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||||||
Equity instruments |
— | — | ||||||||||||||||||
Financial liabilities designated at fair value through profit or loss (1) |
( |
) | — | — | ||||||||||||||||
Others (1)(2) —liabilities: |
— | — | ||||||||||||||||||
At March 31, 2022 |
||||||||||||||||||||
Total fair value measured using valuation techniques |
Effect recorded in profit or loss |
Effect recorded directly in equity |
||||||||||||||||||
Favorable changes |
Unfavorable changes |
Favorable changes |
Unfavorable changes |
|||||||||||||||||
(In millions) |
||||||||||||||||||||
Financial instruments—net: |
||||||||||||||||||||
Derivative financial instruments—net: |
||||||||||||||||||||
Interest rate derivatives—net |
¥ | ( |
) | ¥ | — | ¥ | — | ¥ | — | ¥ | — | |||||||||
Currency derivatives—net |
— | — | ||||||||||||||||||
Equity derivatives—net |
— | — | ||||||||||||||||||
Credit derivatives—net |
— | — | ||||||||||||||||||
Financial assets at fair value through profit or loss: |
||||||||||||||||||||
Debt instruments |
— | — | ||||||||||||||||||
Equity instruments |
— | — | ||||||||||||||||||
Investment securities at fair value through other comprehensive income: |
||||||||||||||||||||
Equity instruments |
— | — | ||||||||||||||||||
Financial liabilities designated at fair value through profit or loss (1) |
( |
) | — | — | ||||||||||||||||
Others (1)(2) —liabilities: |
— | — |
(1) | As part of risk management, the Group enters into transactions to offset the profit or loss of certain financial instruments, including embedded derivatives. Sensitivity of embedded derivatives related to these transactions is presented as derivative financial instruments or financial assets at fair value through profit or loss, according to the presentation of the financial instruments arising from these transactions. |
(2) | Derivatives embedded in financial liabilities, except for financial liabilities designated at fair value through profit or loss, are separately accounted for, but presented together with the host contract in the consolidated statements of financial position. In these tables, the separated embedded derivatives whose host contracts are carried at amortized cost are presented within others. Although the separated embedded derivatives may have a positive or a negative fair value, they have been presented in these tables as liabilities to be consistent with the host contract. |
At September 30, 2022 |
At March 31, 2022 |
|||||||||||||||||
Notes |
Carrying amount |
Fair value |
Carrying amount |
Fair value |
||||||||||||||
(In millions) |
||||||||||||||||||
Financial assets: |
||||||||||||||||||
Investment securities: |
||||||||||||||||||
Debt instruments at amortized cost |
a | ¥ | ¥ | ¥ | ¥ | |||||||||||||
Loans and advances |
b | |||||||||||||||||
Other financial assets |
b | |||||||||||||||||
Financial liabilities: |
||||||||||||||||||
Deposits: |
||||||||||||||||||
Non-interest-bearing deposits, demand deposits and deposits at notice |
c | ¥ | ¥ | ¥ | ¥ | |||||||||||||
Other deposits |
c | |||||||||||||||||
Borrowings |
c | |||||||||||||||||
Debt securities in issue |
c | |||||||||||||||||
Other financial liabilities |
c |
a. |
The fair values of debt instruments at amortized cost are determined using quoted prices in active markets or observable inputs other than quoted prices in active markets. | |||
b. |
(i) | The carrying amounts of loans with no specified repayment dates represent a reasonable estimate of fair value, considering the nature of these financial instruments. | ||
(ii) | Short-term financial assets: The carrying amounts represent a reasonable estimate of fair value. | |||
(iii) | Long-term financial assets: Except for impaired loans and advances, the fair values are mostly determined using discounted cash flow models taking into account certain factors including counterparties’ credit ratings, pledged collateral, and market interest rates. The fair values of impaired loans and advances are generally determined by discounting the estimated future cash flows over the time period they are expected to be recovered, and may be based on the appraisal value of underlying collateral as appropriate. | |||
c. |
Note that some of the financial liabilities in this category include embedded derivatives, which are separately accounted for, but presented together with the host contract. | |||
(i) | The carrying amounts of demand deposits and deposits without maturity represent a reasonable estimate of fair value, considering the nature of these financial instruments. | |||
(ii) | Short-term financial liabilities: The carrying amounts represent a reasonable estimate of fair value. | |||
(iii) | Long-term financial liabilities: The fair values are, in principle, based on the present values of future cash flows calculated using the funding costs for the remaining maturities. The fair values of debt securities in issue are based on a price quoted by a third party, such as a pricing service or broker, or the present values of future cash flows calculated using the rate derived from yields of bonds issued by SMFG, SMBC and other subsidiaries and publicly offered subordinated bonds published by securities firms. | |||
(iv) | The carrying amounts and fair values of lease liabilities are not included in this table. |
19 |
INTEREST RATE BENCHMARK REFORM |
At September 30, 2022 |
||||||||
USD LIBOR (1) |
Others (1) (2) |
|||||||
(In billions) |
||||||||
Carrying amount of non-derivative financial assets |
¥ |
¥ |
||||||
Carrying amount of non-derivative financial liabilities |
— |
|||||||
Derivative notional amounts |
At March 31, 2022 |
||||||||
USD LIBOR (1) |
Others (1) (2) |
|||||||
(In billions) |
||||||||
Carrying amount of non-derivative financial assets |
¥ |
¥ |
||||||
Carrying amount of non-derivative financial liabilities |
— |
|||||||
Derivative notional amounts |
(1) |
The amounts in the tables above are the aggregation of the amounts used for regulatory reporting of SMFG, SMBC, SMBC’s subsidiaries and SMBC Nikko Securities Inc. |
(2) |
“Others” consists of JPY and GBP LIBOR contracts, most of which include contracts that will switch to using alternative reference rates at the next reset after September 30, 2022 and March 31, 2022. It also includes, to a limited extent, synthetic LIBOR contracts that the Group utilized as a temporary solution. |
20 |
EVENTS AFTER THE STATEMENT OF FINANCIAL POSITION DATE |